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 ABSTRACT 
 
Clinical trials have shown that weight reduction with lifestyles can delay or prevent diabetes 
and reduce blood pressure. An appropriate definition of obesity using anthropometric 
measures is useful in predicting diabetes and hypertension at the population level. However, 
there is debate on which of the measures of obesity is best or most strongly associated with 
diabetes and hypertension and on what are the optimal cut-off values for body mass index 
(BMI) and waist circumference (WC) in this regard.  
 
The aims of the study were 1) to compare the strength of the association for undiagnosed or 
newly diagnosed diabetes (or hypertension) with anthropometric measures of obesity in 
people of Asian origin, 2) to detect ethnic differences in the association of undiagnosed 
diabetes with obesity, 3) to identify ethnic- and sex-specific change point values of BMI and 
WC for changes in the prevalence of diabetes and 4) to evaluate the ethnic-specific WC cutoff 
values proposed by the International Diabetes Federation (IDF) in 2005 for central obesity.  
 
The study population comprised 28 435 men and 35 198 women, ≥ 25 years of age, from 37 
cohorts participating in the DECODA and DECODE studies, including 5 Asian Indian (n = 
13 537), 3 Mauritian Indian (n = 4505) and Mauritian Creole (n = 1075), 6 Chinese (n 
=10 801), 1 Filipino (n = 3841), 7 Japanese (n = 7934), 1 Mongolian (n = 1991) and 14 
European (n = 20 979) studies. The prevalence of diabetes, hypertension and central obesity 
was estimated, using descriptive statistics, and the differences were determined with the χ2 
test. The odds ratios (ORs) or  coefficients (from the logistic model) and hazard ratios (HRs, 
from the Cox model to interval censored data) for BMI, WC, waist-to-hip ratio (WHR), and 
waist-to-stature ratio (WSR) were estimated for diabetes and hypertension. The differences 
between BMI and WC, WHR or WSR were compared, applying paired homogeneity tests 
(Wald statistics with 1 df). Hierarchical three-level Bayesian change point analysis, adjusting 
for age, was applied to identify the most likely cut-off/change point values for BMI and WC 
in association with previously undiagnosed diabetes. 
 
The ORs for diabetes in men (women) with BMI, WC, WHR and WSR were 1.52 (1.59), 1.54 
(1.70), 1.53 (1.50) and 1.62 (1.70), respectively and the corresponding ORs for hypertension 
were 1.68 (1.55), 1.66 (1.51), 1.45 (1.28) and 1.63 (1.50). For diabetes the OR for BMI did 
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not differ from that for WC or WHR, but was lower than that for WSR (p = 0.001) in men 
while in women the ORs were higher for WC and WSR than for BMI (both p < 0.05). 
Hypertension was more strongly associated with BMI than with WHR in men (p < 0.001) and 
most strongly with BMI than with WHR (p < 0.001), WSR (p < 0.01) and WC (p < 0.05) in 
women. The HRs for incidence of diabetes and hypertension did not differ between BMI and 
the other three central obesity measures in Mauritian Indians and Mauritian Creoles during 
follow-ups of 5, 6 and 11 years.  
 
The prevalence of diabetes was highest in Asian Indians, lowest in Europeans and 
intermediate in others, given the same BMI or WC category. The  coefficients for diabetes in 
BMI (kg/m
2
) were (men/women): 0.34/0.28, 0.41/0.43, 0.42/0.61, 0.36/0.59 and 0.33/0.49 for 
Asian Indian, Chinese, Japanese, Mauritian Indian and European (overall homogeneity test: p 
> 0.05 in men and p < 0.001 in women). Similar results were obtained in WC (cm). Asian 
Indian women had lower  coefficients than women of other ethnicities.  
The change points for BMI were 29.5, 25.6, 24.0, 24.0 and 21.5 in men and 29.4, 25.2, 24.9, 
25.3 and 22.5 (kg/m
2
) in women of European, Chinese, Mauritian Indian, Japanese, and Asian 
Indian descent. The change points for WC were 100, 85, 79 and 82 cm in men and 91, 82, 82 
and 76 cm in women of European, Chinese, Mauritian Indian, and Asian Indian. The 
prevalence of central obesity using the 2005 IDF definition was higher in Japanese men but 
lower in Japanese women than in their Asian counterparts. The prevalence of central obesity 
was 52 times higher in Japanese men but 0.8 times lower in Japanese women compared to the 
National Cholesterol Education Programme (NCEP) definition.   
 
The findings suggest that both BMI and WC predicted diabetes and hypertension equally well 
in all ethnic groups. At the same BMI or WC level, the prevalence of diabetes was highest in 
Asian Indians, lowest in Europeans and intermediate in others. Ethnic- and sex-specific 
change points of BMI and WC should be considered in setting diagnostic criteria for obesity 
to detect undiagnosed or newly diagnosed diabetes.  
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TIIVISTELMÄ 
 
Epidemiologiset ja kliiniset tutkimukset ovat osoittaneet, että tyypin 2 diabeteksen 
kehittymistä voidaan ehkäistä ja korkeaa verenpainetta voidaan laskea terveellisen 
elintapaohjauksen avulla henkilöillä, joilla on korkea riski tyypin 2 diabetekseen. 
Tarkoituksenmukainen lihavuuden määritelmä pohjautuen antropometrisiin mittauksiin on 
hyödyllinen väestötason tutkimuksissa. Kuitenkaan ei ole yksimielistä näkemystä siitä, onko 
kehon painoindeksi vai vyötärön ympärysmitta parempi ennustamaan tyypin 2 diabetesta ja 
verenpainetautia. Ei ole myöskään selvillä, mitkä ovat painoindeksin ja vyötärönympäryksen 
optimaaliset raja-arvot, joita tulisi tässä yhteydessä soveltaa aasialaisissa ja eurooppalaisissa 
väestöissä.  
   
Tämän väitöskirjatyön tavoitteina oli 1) verrata painoindeksin ja vyötärön ympärysmitan 
yhteyden voimakkuutta aikaisemmin toteamattomassa tai vastatodetussa diabeteksessa (ja 
verenpainetaudissa) aasialaista alkuperää olevilla henkilöillä, 2) todeta etnisien ryhmien 
välisiä eroja edellä mainituissa yhteyksissä, 3) identifioida ikä- ja sukupuolikohtaiset 
painoindeksin ja vyötärön ympärysmitan raja-arvot ennustamaan diabeteksen vallitsevuuden 
muutosta eri etnisessa ryhmissä and 4) arvioida vyötärön ympärysmitan raja-arvoja, jotka 
International Diabetes Federation (IDF) on vuonna 2005 ehdottanut eri etnisille ryhmille 
tarkoittamaan keskivartalolihavuutta. 
 
Tutkimuksen aineisto koostuu 37 aasialaisesta ja eurooppalaisesta kohortista DECODA ja 
DECODE tutkimuksissa, joihin osallistui yhteensä 28 435 miestä ja 35 198 naista, iältään yli 
25 vuotiaita. Näistä kohorteista, 5 oli Intiasta (n =13 537), 3 Mauritukselta (n= 4505 
alkuperältään intialaisia ja n= 1075 kreolejaa), 6 Kiinasta (n=10 801), yksi Filippiineiltä (n= 
3841), 7 Japanista (n= 7934), yksi Mongoliasta (n= 1991) ja 14 Eurooppasta (n= 20 979). 
Tyypin 2 diabeteksen, verenpainetaudin, ja vyötärölihavuuksen prevalenssit laskettiin. 
Antropometristen muuttujien ja eri etnisten ryhmien välisiä eroja testattiin käyttäen useita 
tilastomenetelmiä kuten χ2 testi, Waldin testi, logistinen regressioanalyysi ja Coxin 
regressioanalyysi. Vedonlyöntisuhdetta (Odds ratio, OR) tai -kertoimia logistisesta mallista 
ja vaarasuhteita (Hazards ratio, HR) Coxin mallista sovellettiin analyyseissä, joissa tutkittiin 
painoindeksin, vyötärön ympärysmitan, vyötärö-lantio suhteen ja vyötärö-pituus suhteen 
yhteyttä diabetekseen ja verenpainetautiin. Näiden antropometristen muuttujien välisiä eroja 
kyseisissä analyyseissä arvioitiin parittaisilla homogeenisyystesteillä (Waldin testi, 1 
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vapausaste). Hierarkkista kolmen tason Bayesilaista ikävakioitua muutoskohta-analyysiä  
sovellettiin etsittäessä todennäköisintä muutoskohtaa painoindeksille ja vyötärön 
ympärysmitalle toteamaan aikaisemmin diagnosoimaton diabetes. 
 
OR:t painoindeksille, vyötärön ympärysmitalle, vyötärö-lantio suhteelle ja vyötärö-pituus 
suhteelle diabeteksen suhteen olivat miehillä (naisilla) 1.52 (1.59), 1.54 (1.70), 1.53 (1.50) ja 
1.62 (1.70). Vastaavat OR:t verenpainetaudin suhteen olivat 1.68 (1.55), 1.66 (1.51), 1.45 
(1.28) ja 1.63 (1.50). OR painoindeksille ei eronnut OR:sta vyötärön ympärysmitalle tai 
vyötärö-lantio suhteelle, mutta oli pienempi kuin OR vyötärö-pituus suhteelle (p = 0.001) 
miehillä, kun taas naisilla OR vyötärön ympärysmitalle tai vyötärö-pituus suhteelle olivat 
suuremmat kuin painoindeksille (molemmat p < 0.05). Painoindeksin yhteys 
verenpainetautiin oli voimakkaampi kuin vyötärö-lantio suhteen miehillä (p < 0.001), ja 
naisilla painoindeksin yhteys oli voimakkaampi kuin vyötärön ympärysmitan (p < 0.05), 
vyötärö-lantio suhteen (p < 0.001) ja vyötärö-pituus suhteen (p < 0.001). HR:t diabeteeksen ja 
verenpainetaudin esiintyvyydelle eivät eronneet painoindeksin ja kolmen muun 
antropometrisen muuttujan välillä mauritiuslaisilla intialaisilla ja kreoleilla. 
 
Tyypin 2 diabeteksen prevalenssi oli korkein intialaisilla, matalin eurooppalaisilla ja 
keskitasolla muissa Aasialaisissa väestöissä. Logistisen regressiomallin arviodut 
painoindeksin (kg/m
2
) - kerroimet diabetekselle olivat (mies/nainen): 0.34/0.28, 0.41/0.43, 
0.42/0.61, 0.36/0.59 ja 0.33/0.49 intialaisilla, kiinalaisilla, japanilaisilla, mauritiuslaisilla 
intilaisilla ja eurooppalaisilla (kokonais-homogeenisuustesti: p > 0.05 miehillä ja p < 0.001 
naisilla). Intialaisilla naisilla oli pienempi -kerroin kun muilla naisilla. Painoindeksin 
muutoskohdaksi diabetesriskin suhteen todettiin 29.5, 25.6, 24.0, 24.0 ja 21.5 kg/m
2 
miehillä 
ja 29.4, 25.2, 24.9, 25.3 ja 22.5 naisilla kg/m
2
 eurooppalaisilla, kiinalaisilla, mauritiuslaisilla 
intialaisilla, japanilaisilla ja intialaisilla. Vyötärön ympärysmitan muutoskohdaksi 
diabetesriskin suhteen todettiin 100, 85, 79 ja 82 cm miehillä ja 91, 82, 82 ja 76 cm naisilla 
eurooppalaisilla, kiinalaisilla, mauritiuslaisilla intialaisilla ja intialaisilla. Sovellettaessa IDF:n 
2005 ehdottamia vyötärön ympärysmitan raja-arvoja keskivartalolihavuudelle, sen 
vallitsevuus oli japanilaisilla miehillä korkeampi kuin muissa aasialaisissa väestöissä. 
Verrattuna Yhdysvaltojen National Cholesterol Education Program (NCEP):n käyttämiin raja-
arvoihin keskivartalolihavuuden vallitsevuus oli IDF:n raja-arvoja käytettäessä 52 kertaa 
korkeampi japanilaisilla miehillä, mutta 0.8 kertaa matalampi japanilaisilla naisilla. 
12 
 
Nämä löydökset osoittavat sekä painoindeksin että vyötärön ympärysmitan ennustavan 
diabeteksen ja verenpainetaudin esiintyvyyttä yhdenmukaisesti kaikissa etnisissä ryhmissä. 
Samalla painoindeksin ja vyötärön ympärysmitan tasolla diabeteksen vallitsevuus oli korkein 
intialaisilla ja matalin eurooppalaisilla. Etnis- ja sukupuoli-kohtainen painoindeksin ja 
vyötärön ympärysmitan raja-arvoja tulee soveltaa ennustettaessa diabeteksen riskiä liittyen 
lihavuuteen.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
1 INTRODUCTION 
Obesity is an excess fat accumulation in the body that is one of the major modifiable risk 
factors for type 2 diabetes, hypertension and many other chronic conditions (Colditz et al. 
1995; Huang et al. 1998; Zimmet et al. 2001). The World Health Organization (WHO) 
estimates that there are more than 1 billion overweight adults worlwide and at least 300 
million that are clinically obese (WHO Consultation 2000), figures that are estimated to 
increase further by 2015. Increased urbanization, westernization, rapid economic development 
and unhealthy lifestyles all have contributed to the rapid increase in obesity. Consequently, 
the prevalence of obesity-related metabolic disorders, such as type 2 diabetes and many 
others, are increasing at an alarming rate and projected to increase further.  
 
Diabetes is the fifth or sixth leading cause of death (International Diabetes Federation 2009). 
The crude prevalence of diabetes (types 1 and 2) in adults 20-79 years of age was estimated to 
be 6.6% (285 million) in 216 IDF member countries in 2010 (International Diabetes 
Federation 2009). By 2030, this figure is expected to rise to 7.8% (438 million), with the 
largest increase in regions where economies are developing further. They further emphasized 
that if the levels of obesity continue to increase, the prevalence of diabetes may be even 
greater than that reported in the IDF 2009 report.  
 
Hypertension is considered as the primary risk factor for stroke, ischemic heart disease 
(Nakamura et al. 2008) and cardiovascular disease (CVD) mortality (Martiniuk et al. 2007; 
He et al. 2009). Recently, it was estimated that 7.6 million premature deaths per year may be 
attributed to high blood pressure (Lawes et al. 2008), that is 13.5% of the total global deaths. 
About 26.4% or 972 million of the world adult population had hypertension in 2000, of which 
333 million were in economically developed countries and 639 million in economically 
developing countries (Kearney et al. 2005), figures predicted to increase by 60% to 1.56 
billion in 2025.  
 
Clinical intervention trials have clearly shown that weight reduction with healthy diets and 
physical activity can benefit individuals at increased risk for diabetes and hypertension 
(Eriksson and Lindgarde 1991; Pan et al. 1997; Tuomilehto et al. 2001; Knowler et al. 2002; 
Appel et al. 2003; McGuire et al. 2004; Kosaka et al. 2005; Elmer et al. 2006; Ramachandran 
et al. 2006; Bosworth et al. 2007; Cook et al. 2009). Thus, an appropriate definition of obesity 
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and its predictive value in relation to diabetes and hypertension are necessary in intervention 
strategies in different populations.  
 
Commonly used proxy or anthropometric measures such as body mass index (BMI), waist 
circumference (WC), waist-to-hip ratio (WHR), hip circumference and waist-to-stature ratio 
(WSR) have been proposed to define obesity in epidemiological studies. However, there is 
controversy regarding which of these anthropometric measures best defines obesity and 
conveys the highest risk for type 2 diabetes and hypertension (Wei et al. 1997; Folsom et al. 
2000; Tulloch-Reid et al. 2003; Hayashi et al. 2004; Menke et al. 2007; Zhou et al. 2009). 
Furthermore, optimal BMI and WC cut-off values for detecting diabetes, other metabolic 
abnormalities, and CVD were proposed for different populations, with higher values for 
Europeans and lower values for Asians (Han et al. 1995; Lean et al. 1995; Regional Office for 
the Western Pacific of the World Health Organization 2000; WHO Consultation 2000; Expert 
Panel on Detection 2001; WHO Expert Consultation 2004; Alberti et al. 2005, 2006). 
Comparability of findings within the same ethnicity, however, is limited, which may be due to 
variations in age range of the study population and the statistical methods applied.  
 
The Diabetes Epidemiology: Collaborative Analysis Of Diagnostic criteria in Asia/Europe 
(DECODA/DECODE) studies, consisting of 37 cohorts of European and Asian origin provide 
an excellent opportunity for comparison of surrogate anthropometric measures for obesity 
with undiagnosed diabetes and hypertension, based on both cross-sectional and prospective 
data. In addition, they can be used to explore ethnic differences in the strength of association 
of undiagnosed diabetes, given the same obesity level and to identify the cutoff values for 
BMI or WC in different ethnic groups, using standardized statistical methods.  
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2 LITERATURE REVIEW 
2.1 Epidemiology of obesity 
2.1.1 Clinical definition and classification of overweight and obesity 
Obesity, as an excess body fat accumulation, is increasing in both the developed and 
developing world (WHO Consultation 2000). The use of different anthropometric measures 
has been proposed by various organizations to classify overweight and obesity in adults 
(Table 1). 
 
Table 1 Classification of overweight and obesity by different international organizations 
 (WHO 
Consultation 
2000) 
WHO (Lean et al. 
1995) 
NCEP (Expert Panel on 
Detection 2001) 
IDF (Alberti et al. 
2006)   
 BMI (kg/m
2
) WC (cm) WC (cm) WC  (cm) 
Underweight  < 18.5    
Normal weight 18.5 - 24.9    
Overweight 25.0 - 29.9    
Obesity ≥ 30.0 ≥94/80 
men/women 
> 102/88 men/women ≥ 94/80 or 90/80  
men/women 
WC of ≥ 94/80 cm in men/women for European, Eastern Mediterranean, Middle East (Arab) and  
Sub-Saharan African and ≥ 90/80 cm for Chinese, Japanese, South Asians and South and Central 
American men/women, respectively  
 
The WHO definition classified individuals into different stages of obesity using BMI (WHO 
Consultation 2000) while the National Cholesterol Education Programme (NCEP) (Expert 
Panel on Detection 2001) and IDF classified individuals as obese and non-obese, using 
ethnic-specific WC with purpose to define the metabolic syndrome (Alberti et al. 2005, 2006). 
Furthermore, in the 2005 IDF definition, central obesity was a mandatory component of the 
metabolic syndrome and WC values of 85/90 cm for Japanese men/women were set as criteria 
for central obesity (Alberti et al. 2005). 
Overall fatness or general obesity, as measured by BMI was introduced as Quetelet’s index 
(Garrow and Webster 1985) and central/abdominal obesity was first introduced by the French 
physician Vague in the late 1940s (Vague 1947). Later, Vague pointed out for the first time 
that central (android) obesity was more detrimental than peripheral obesity (gynoid) in 
relation to diabetes, gout, atherosclerosis and urate calculus diseases (Vague 1956). Since that 
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time, a number of studies confirmed the association of android type obesity with different 
morbidity outcomes. At the adipocyte level, the two different patterns of obesity, hypertrophic 
(increased size alone) and hyperplastic (increased cell number with normal or increased size) 
obesity (Salans et al. 1973; Bjorntorp 1991), were further recognized in human obesity with 
distinct clinical consequences (Salans et al. 1968; Krotkiewski et al. 1983; Weyer et al. 2000). 
People with hypertrophic obesity were seen as more likely to develop obesity-related 
metabolic disturbances than those with hyperplastic obesity (Arner et al. 2010)  
2.1.2 Anthropometric measures of obesity  
BMI as a measure of general obesity, and WC and WHR as measures of central obesity, have 
been proposed to define obesity (Seidell et al. 1989). The most common measure that has 
been used is the BMI. BMI is calculated as the weight in kilograms divided by the square of 
the height in metre (kg/m
2
) and its concept dates back to 1869 as Quetelet’s index (Garrow 
and Webster 1985), which was shown as a fairly good indicator of general fatness (Seidell et 
al. 1989; WHO Expert Commiittee 1995; WHO Consultation 2000). However, despite its use 
in epidemiological and clinical studies, for a given BMI, the adiposity varies by age, sex and 
ethnicity (Deurenberg et al. 2002).  
Since the early 1980s, the waist-thigh-ratio or WHR has been considered more closely 
correlated with abdominal visceral fat than the BMI and a better predictor of CVD or diabetes 
incidence than the BMI (Ashwell et al. 1982; Krotkiewski et al. 1983; Lapidus et al. 1984; 
Larsson et al. 1984; Ashwell et al. 1985; Ohlson et al. 1985). Since the 1990s, interest in WC 
has increased because it correlates more closely with abdominal visceral fat than either the 
WHR or BMI (Pouliot et al. 1994; Han et al. 1995; Lean et al. 1995; Han et al. 1998) for 
identification of CVD risk factors. Other indicators, such as hip circumference (Lissner et al. 
2001; Seidell et al. 2001; Snijder et al. 2003; Snijder et al. 2004), waist-to-height ratio 
(WHtR) (Ashwell et al. 1996a; Ashwell et al. 1996b; Ledoux et al. 1997; Hsieh and Muto 
2005) and WSR (Ho et al. 2003) may also be useful markers of obesity. 
2.1.3 Measurements of waist and hip circumference 
In the literature, there are as many as 14 different anatomical sites at which WC can be 
measured (Wang et al. 2003). The WC measurement sites most widely used in 
epidemiological studies are shown in Table 2.  
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Table 2 Anatomical sites for waist circumference measurement 
Measurement sites Proposed organization Reference 
Waist circumference   
Below the lowest rib  (Wang et al. 2003) 
Minimal waist Anthropometric Standardization 
Reference Manual 
(Lohman 1988) 
Midpoint between the 
lowest rib and the iliac crest 
WHO STEPS protocol (WHO 2008) 
Umbilicus  or navel level NIH MESA protocol (MESA Monitoring Board 
2002) 
Above the iliac crest NIH and NHANES III protocol (Westat 1988) 
Hip circumference   
The widest portions of 
the buttocks 
WHO STEPS, MESA, 
and NHANES III protocols 
(Westat 1988; MESA 
Monitoring Board 2002; WHO 
2008) 
 
According to the WHO Stepwise Approach to Surveillance (STEPS) protocol, the WC should 
be measured at the midpoint between the top of the iliac crest (hip bone) and the lower margin 
of the last palpable rib (WHO 2008), which is the method most commonly used. A second 
protocol, used by the National Institutes of Health (NIH) Multiethnic Study of Atherosclerosis 
(MESA), suggests measuring the WC at the umbilicus or navel level (MESA Monitoring 
Board 2002). A less frequently used method, provided in the NIH manual (National Institute 
of Health 2000) and the National Health and Nutrition Examination Survey III (NHANES III) 
(Westat 1988), advises measuring the WC from the top of the iliac crest.  
There is generally more consensus on existing recommendations for measuring hip 
circumference around the widest portion of the buttocks (Westat 1988; MESA Monitoring 
Board 2002; WHO 2008).  
2.1.4 Measurement error related to BMI and WC 
Currently, there is no consensus regarding the optimal protocol for measurement of WC and 
no scientific rationale supporting the measurement protocols recommended. Another 
important consideration in choosing an anthropometric measure of BMI or WC as a screening 
tool is the measurement error. Some investigators have argued that measurement of the WC is 
subject to less error because only a single measurement is required, which favours the use of 
the WC rather than the BMI. In a review, measurements of weight and height appeared to be 
most precise among different anthropometric measures, while WC showed strong 
interobserver differences (Ulijaszek and Kerr 1999). Two other studies have also shown a 
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significant interobserver difference in WC measurements, as well as higher interobserver 
variability for the WC than for the BMI (Nadas et al. 2008; Panoulas et al. 2008). Training, in 
the form of written instructions, eliminates the systematic error but does not reduce the 
overall variation in WC measurements between observers (Panoulas et al. 2008). Although 
the various measurement protocols have no substantial influence on the association between 
WC and health outcomes (Ross et al. 2008), they will increase the difficulties in comparing 
directly between studies. Hence the measurement of WC is recommended, due to its close 
association with unfavourable health consequences, not because its measurement error is less. 
In addition to the advantages of these anthropometric measures, such as low cost and less 
labour, there are, potential disadvantages such as ratios difficult to interpret biologically for 
the WHR or BMI, changes in body fat or visceral fat result little or no change in this ratio 
(Bouchard et al. 1990), and high levels of correlation of these measures, such as WC with 
BMI (Molarius and Seidell 1998).    
2.1.5 Adult prevalence, secular trend and risk factors for obesity 
Generally, most of the populations experienced an increase in the prevalence of obesity in the 
last decade, most likely due to lifestyle changes associated with urbanization, westernization 
and economic development. Similarly the increase in prevalence of obesity was reported in all 
populations in the WHO MONICA study between the 1980s and 1990s, due to increased 
enegy supply (Silventoinen et al. 2004). In recent years, there has been increasing recognition 
that developing countries that still have a substantial problem of undernutrition are now 
facing an epidemic of both obesity and undernutrition (Prentice 2006). The most recent adult 
prevalence of obesity is shown in Appendix 1. The prevalence of obesity ranged from 0.3 -
3.4% in Asian Indians, Filipinos, Japanese and Chinese (Asia Pacific Cohort Study 
Collaboration 2007) to 4.7 - 9.1% in Thais (Aekplakorn and Mo-Suwan 2009), Hong Kong 
Chinese (Asia Pacific Cohort Study Collaboration 2007) and Singaporeans (Ministry of 
Health Singapore 2005). The prevalence was between 6.0% and 9.3% in men and 12.0% and 
25.0% in women from Africa (Bovet et al. 2002), Mauritius (International Obesity Task 
Force), Brazil (Monteiro et al. 2007) and Mongolia (Bolormaa et al. 2008). The prevalence of 
obesity ranged from 10.0 - 15.5% in the Netherlands, Spain (DORICA) and Sweden (Berg et 
al. 2005; Schokker et al. 2007; Aranceta et al. 2009) to 19.3 - 27.7 % in Finland (Vartiainen et 
al. 2010), Spain (Girona) (Schroder et al. 2007), Australia (Cameron et al. 2003), Canada 
(Shields et al. 2010), the UK (Zaninotto et al. 2009), Italy (Berghofer et al. 2008) and Mexico 
(Malina et al. 2007), with similar rates in men and women. In the USA, the prevalence of 
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obesity was over 32.0%, with higher rates in Mexican Americans and Blacks than in Whites 
(Flegal et al. 2010).     
As shown in Appendix 2, the increasing trend toward increase in prevalence of obesity was 
observed in most of the populations, with a few exceptions; in India, Mongolia and the USA 
the prevalence did not increase in the last decade. The prevalence was doubled in Brazil, 
China and Thailand.  
 
Genes, age and female sex (in Central and Eastern Europe, Latin America, Asia and Africa), 
all have been considered as nonmodifiable risk factors for obesity. In 2007, Fat Mass and 
Obesity (FTO) gene variants predisposed individuals to type 2 diabetes through their effect on 
BMI in the European population (Frayling et al. 2007). The findings were further confirmed 
in Chinese (Liu et al. 2010), Japanese (Karasawa et al. 2010), Asian Indians (Yajnik et al. 
2009) and Hispanic and African Americans (Wing et al. 2009). Recently, other new gene 
variants with a population-level effect on BMI and WC (or WHR) have been identified 
(Lindgren et al. 2009; Willer et al. 2009). Obesity increases with age in both sexes, especially 
in women (Berg et al. 2005; Wang and Beydoun 2007; Wang et al. 2007; Low et al. 2009; 
Wang et al. 2009; Zaninotto et al. 2009; Flegal et al. 2010; Lahti-Koski et al. 2010) with a 
peak prevalence at 50 - 60 years in developed and 40 - 50 years in developing countries (Low 
et al. 2009). Individuals, particularly women with low socioeconomic status (SES), were more 
obese in highly developed countries mostly (Molarius et al. 2000; Seidell 2005; McLaren 
2007) but women with high SES were more obese in low- and medium-development regions, 
such as in Africa (Martorell et al. 2000; Amoah 2003; McLaren 2007; Case and Menendez 
2009) and India (Wang et al. 2009).   
2.2 Obesity and diabetes  
2.2.1 Definition, prevalence and secular trend in the prevalence of type 2 diabetes  
Diabetes was defined as fasting glucose (FG) ≥ 7.00 mmol/l and/or 2-hour postchallenge 
glucose (2h-PG) ≥ 11.10 mmol/l by the WHO (WHO Consultation 1999), American Diabetes 
Association (American Diabetes Association 2010) and the IDF (International Diabetes 
Federation 2009). The prevalence of type 2 diabetes is increasing continuously with time in 
all populations and is reaching epidemic proportions in some populations, such as in Nauru 
(Chan et al. 2009). In Sub-Saharan African populations, the prevalence of type 2 diabetes was 
between 2.0% and 3.0% (Gill et al. 2009). The prevalence of diabetes ranged from 5.1% in 
Filipinos to 8.2% in Mongolians (Bolormaa et al. 2008). In China, a recent national survey 
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revealed that 9.7% of adults had diabetes in 2007 (Yang et al. 2010), which was similar to the 
prevalence in Hong Kong (Janus et al. 2000) and Japan (Ekoe et al. 2008). In India, 4.3% of 
the adult population had type 2 diabetes in a national report (Sadikot et al. 2004), but a much 
higher prevalence of 18.6% in Chennai city was reported (Ramachandran et al. 2008). For 
European countries (Figure 1), the prevalence (types 1 and 2) ranged from 3.6% in England to 
7.3 - 8.8% in Sweden, Netherlands, Finland, Spain and Italy in order of increase (International 
Diabetes Federation 2009), with the highest prevalence of 12.0% in Germany and 10.4% in 
Cyprus. In the USA, the prevalence was 12.9% (Cowie et al. 2009).  
 
 
Figure 1 Prevalence (%) estimates of diabetes (20-79 years) in 2010.   
Diabetes Atlas 4
th
 edition (International Diabetes Federation 2009) 
In China, the prevalence of diabetes increased from 1.0% to 9.7 % between 1980 and 2007 
(Yang et al. 2010). The prevalence more than doubled in Mongolia from 1999 (3.2%) to 2005 
(8.2%) (Bolormaa et al. 2008). Several population-based studies from India and Mauritius 
reported that the prevalence of diabetes increased (Ramachandran et al. 1992; Ramachandran 
et al. 2001; Mohan et al. 2006; Ramachandran et al. 2008). In Europe, the prevalence 
increased in the Netherlands (Ubink-Veltmaat et al. 2003), Sweden (Berger et al. 1999) and 
the UK (Gatling et al. 1998) and doubled in Australia between 1981 and 1999 - 2000 
(Dunstan et al. 2002). The continuous increase in diabetes prevalence was observed in the 
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USA as from 5.3% (1976 - 1980) to 12.9% (2005 - 2006) (Gregg et al. 2004; Cowie et al. 
2009).   
2.2.2 Risk factors for type 2 diabetes 
Since 2000, genomewide association studies have suggested a number of gene variants that 
are associated with a high risk for type 2 diabetes (Prokopenko et al. 2008; Florez 2009; 
Dupuis et al. 2010). More recently, the FTO gene predisposes individuals to diabetes through 
an effect of BMI in many different ethnic groups (Frayling et al. 2007; Wing et al. 2009; 
Yajnik et al. 2009; Karasawa et al. 2010a; Liu et al. 2010). Some ethnic groups, e.g. Asian 
Indians had a higher prevalence of diabetes than Caucasians in the USA (Abate et al. 2003; 
Abate et al. 2005; Radha et al. 2006), due to genetic predisposition. Individuals with family 
histories of diabetes in their parents or siblings had from 2 to 6 times higher risk for diabetes 
than those without it (Knowler et al. 1981; Lin et al. 1994; Sargeant et al. 2000; Harrison et al. 
2003; Valdez et al. 2007; Valdez 2009). Diabetes increased with age in both men and women 
of all populations in the DECODA/DECODE studies (Qiao et al. 2003; The DECODE Study 
Group 2003). 
Among the lifestyle-related risk factors, Pietraszek et al. demonstrated J- or U-shaped 
associations between alcohol consuption and incidence of type 2 diabetes, based on meta-
analysis and cohort studies (Pietraszek et al. 2010). Compared with abstainers, moderate 
alcohol consumers had 30% reduced risk for diabetes, due to an ethanol-mediated 
improvement in insulin sensitivity primarily observed in the obese, while heavy consumers 
had the same or higher risk (Pietraszek et al. 2010). As for association of smoking with type 2 
diabetes, the results were inconsistent. Some studies have shown that current smoking 
increased the risk of diabetes incidence by 44% (Willi et al. 2007) and 31% (Yeh et al. 2010) 
while in other study a reduced risk of diabetes was noted (Onat et al. 2007). Recent studies 
from China demonstrated that low SES increased the risk for diabetes (Yang et al. 2010) in 
urban men only, but lowered the risk in rural men of Qingdao city, which was mediated partly 
by obesity (Ning et al. 2009). 
2.2.2.1 Obesity as a major risk factor for type 2 diabetes 
Obese women were at higher risk of developing type 2 diabetes during a 14-year follow-up, 
5-fold in the BMI group of 24.0 - 24.9 kg/m
2
, 40-fold in 31.0 - 32.9 kg/m
2
 and 93-fold in the 
35.0 kg/m
2
 category, compared with the group with BMI of < 22.0 kg/m
2
 in the large Nurse’s 
Health Study (Colditz et al. 1995) as well as in the Male Health Professionals in the USA 
(Chan et al. 1994) during a 7-year follow-up. A 20-year follow-up of the Nurse’s Health 
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Study further confirmed that weight increase as a major risk factor for type 2 diabetes in all, 
particularly in Asians (Shai et al. 2006), which was in agreement with findings from others 
(Ning et al. 2009). Prospective studies have reported a strong association between daily 
physical activity and reduced risk for developing diabetes, with a relative risk reduction of 15 
- 60% (Helmrich et al. 1991; Perry et al. 1995; Hu et al. 1999; Hu et al. 2004; Nakanishi et al. 
2004; Meisinger et al. 2005). Furthermor, clinical intervention trials have clearly shown that 
weight reduction with healthy diet and physical activity can prevent or at least delay the onset 
of type 2 diabetes in individuals with impaired glucose tolerance in Swedish (Eriksson and 
Lindgarde 1991), Chinese (Pan et al. 1997), Finnish (Tuomilehto et al. 2001), American 
(Knowler et al. 2002), Asian Indians (Ramachandran et al. 2006) and Japanese subjects 
(Kosaka et al. 2005). The relative risk reduction for diabetes ranged from 28% in Asian 
Indians to 67% in Japanese during the intensive intervention period. Furthermore, these trials 
demonstrated that lifestyle intervention was as effective as metformin (Knowler et al. 2002; 
Ramachandran et al. 2006; Knowler et al. 2009) or pioglitazone (Ramachandran et al. 2009). 
This suggests that weight reduction with a healthy lifestyle is the cornerstone in prevention of 
obesity-related conditions such as diabetes.  
2.2.3 Comparison of BMI with central obesity measures in relation to type 2 diabetes  
Controversial opinions exist on which of these obesity measures, BMI or WC (WHR or 
WSR) are more strongly associated with increased risk of type 2 diabetes and need to be 
studied further, based on prospective studies with an incidence of diabetes as an outcome.  
Since the 1990s, a number of epidemiological studies and meta-analyses of the comparison 
between BMI and WC (or WHR) for assessing type 2 diabetes have been carried out in 
different ethnic groups. A meta-analysis of 35 cohort studies that examined the association 
between different anthropometric measures of obesity and incident diabetes has shown that 
the pooled relative risk for diabetes incidence did not differ significantly between BMI and 
WC or WHR (Vazquez et al. 2007). A stronger association with WSR than with BMI was 
observed in males only and there were no differences in females between the four measures 
(BMI, WC, WHR, and WSR) for presence of diabetes, based on meta-analysis (Lee et al. 
2008a). WC (not for Asian men) and WHR were more strongly associated with prevalent 
diabetes than with BMI in Asian and Caucasian women, but these measures did not differ in 
Caucasian men in the Obesity in Asia Collaboration study (OAC) (Huxley et al. 2008). 
Recently, we published a review article on studies (17 prospective and 35 cross-sectional) that 
compared the performance of anthropometric measures with diabetes (Qiao and Nyamdorj 
2010a). For prospective studies, in which formal statistical tests were done, inconsistent 
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findings were observed: in favour of the WC in Mexican Americans and African Americans 
but in favour of the BMI in Pima Indians, and no differences were found in the Diabetes 
Prevention Programme (DPP) study. Among 11 cross-sectional studies that have formally 
tested the differences, most found a slightly higher odds ratio (OR) or larger area under the 
receiver-operating characteristics (ROC) curve (AUC) for WC than for BMI. All studies 
included in the review showed that either BMI or WC (or WHR or WSR) predicted or was 
associated with type 2 diabetes independently, regardless of the controversial findings on 
which of these obesity indicators is better (Qiao and Nyamdorj 2010a).  
2.2.4 Optimal cutoff values for BMI and WC in relation to diabetes  
Currently, different definitions for obesity, using WC has been proposed by different 
organizations in various populations. Central obesity, using ethnic-specific WC values, is 
used with purpose to define the metabolic syndrome. In addition, the recommended cutoff 
values for WC and BMI for detecting diabetes differ among ethnic groups (Regional Office 
for the Western Pacific of the World Health Organization 2000; WHO Expert Consultation 
2004; Alberti et al. 2009; Qiao and Nyamdorj 2010b), with lower values for Asians and 
higher for Europeans. However, the comparability of the cutoff values is limited within 
populations of the same ethnicity which may be due to variation in age range of the study 
participants or to the methods applied to determine the optimal cutoff values in different 
studies. All studies aiming to choose BMI and WC cutoff values almost exclusively used the 
ROC curve approach, in which the sum of the sensitivity and specificity was maximized, but 
choosing the WC values using this approach was considered inappropriate (Cameron et al. 
2009). No consensus has been reached regarding the most appropriate approach for selecting 
WC cutoff values. Furthermore, no results are available that apply Bayesian change point 
analysis to detect the diagnostic cutoff values. All these suggest that studies are needed for 
appropriate definition of obesity, using standardized methods in different populations.  
 
Our review (based on 4 prospective and 24 cross-sectional studies) has also shown the marked 
variation in cutoff values between ethnic groups, as summarized in Table 3 (Qiao and 
Nyamdorj 2010b). Tongans had the highest BMI and WC optimal cutoff values (not for 
WHR), followed by studies in the USA and the UK. The BMI and WC cutoff values were 
higher for ethnicities in the USA and the UK studies than in their counterparts in their original 
countries. The optimal cutoff values for BMI were 27 - 28 kg/m
2
 in White men and women 
(Australia, Germany, France (men only), the UK and the USA) but were 30 kg/m
2
 for men in 
the NHANES III and 25 kg/m
2
 for women from France. The optimal WC (WHR) cutoff 
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values were 97 - 99 cm (0.95) for White men and 85 cm (0.83 - 0.85) for White women living 
outside the USA and the UK. The values for BMI were 23 - 24 kg/m
2
 in Chinese, Japanese, 
and Thai men and 22 - 23 kg/m
2
 in Indians. The optimal cutoff values for WC were 85 cm 
(0.90) for Chinese, Japanese, Indian, and Thai men and 75 - 80 cm (0.79 - 0.85) for women in 
these ethnic groups from Asia; the values for other ethnic groups were between those for 
Whites and Asians. White, Chinese, Japanese, Indian and Bangladeshi men had higher values 
than women of these ethnicities, but Thai, Iranian, Iraqi, Tunisian, Mexican, African and 
Tongan men did not.   
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Table 3 Optimal BMI, WC, and WHR cutoff points (CP) for assessing risk of type 2 diabetes with sensitivity (Sen) (%) and specificity  
(Spe) (%) (Qiao and Nyamdorj 2010b) 
 
Ethnicity Men Women 
 BMI (kg/m
2
) WC (cm) WHR BMI (kg/m
2
) WC (cm) WHR 
 CP Sen Spe CP Sen Spe CP Sen Spe CP Sen Spe CP Sen Spe CP Sen Spe 
White 
(Others) 
 
27-
28 
60-
77 
64-
70 
97-
99 
72 74 0.95 77 65 27-
28 
65-
86 
63-
70 
85 77 74 0.83-
0.85 
77 70 
White 
(USA,UK) 
28-
30 
60 70 101-
6 
61 67 0.97 69 58 27-
28 
65 69 95 67 68 0.91 69 64 
Turkish 
(Turkey) 
    95 70 53        91 75 55    
Chinese  24 58-
89 
59-
66 
85 50-
97 
58-
70 
0.88-
0.92 
64-
76 
71-
76 
24 61-
81 
52-
75 
75-
80 
58-
78 
66-77 0.79-
0.83 
71-
79 
70-79 
Chinese 
(USA+UK) 
25   95      24   84      
Indian 
(India) 
22-
23 
67-
78 
48-
63 
85-
87 
64-
69 
58-
67 
0.92 61 66 23 67-
72 
53-
54 
80-
83 
65-
70 
56-60 0.85 66 54 
Indian 
(USA+UK) 
27   97      25   89      
Bangladeshi 
(USA+UK) 
24   96      27   88      
Pakistani 
(USA+UK) 
25   93      30   101      
Japanese 
(Japan) 
24 59 59 85 62 62 0.92 71 71 23 67 67 73 70 70 0.81 78 78 
Thai 
(Thailand) 
23   85   0.91   25   85   0.88   
Iranian 
(Iran) 
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18-34 yr    86   0.88      82   0.82   
35-54 yr    91   0.94      93   0.87   
55-74 yr    92   0.96      95   0.91   
Iraqi (Iraq) 25 66 54 90 80 49 0.92  77 61 26 66 47 91 80 47 0.91 72 63 
Tunisian 
(Tunisia) 
   85 71 63       85 76 67    
Tongan 
(Tonga) 
32 66 68 103 63 64 0.93 69 71 35 62 61 103 65 63 0.86 69 71 
Brazilian 
(Brazil) 
   88 69 68       84 67 66    
Mexican 
(Mexico) 
27 56 56 90-
95 
47 47 0.90 57 57 28 59 59 85-
97 
53 53 0.86 62 62 
Mexican 
(USA+UK) 
28   100      30   104      
African 
(USA) 
28 61 68 99 61 71 0.94 62 60 30 63 60 101 62 68 0.92 61 66 
African  25 71 71 88 71 79 0.87   29 62 65 85-
89 
62 65 0.90   
Black 
(USA+UK) 
29- 
32 
  109-
100 
     28   105-
88 
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2.2.5 Ethnic differences in the association of diabetes with obesity  
The evidence shows that at any given level of BMI, WC, WHR or visceral adipose tissue 
accumulation, non-Europeans have greater risk of developing diabetes than Europeans. 
However, inconsistent results in the strength of the association of diabetes with obesity 
measures were found in different ethnic groups, which needs further investigation. 
 Studies revealed ethnic differences in the prevalence or incidence of diabetes as well as in the 
association of diabetes with different obesity measures, based on cross-sectional 
(Ramachandran et al. 1997; McBean et al. 2004; Lee et al. 2007; Sundborn et al. 2007) and 
prospective data (Shai et al. 2006; Signorello et al. 2007; Vazquez et al. 2007). However, few 
studies have compared the strength of the association across ethnic groups given the same 
level of obesity. In comparison to Caucasians, non-Europeans (Aboriginal people, South 
Asians and Chinese in Canada), Aboriginals (Australia) and Asians from different countries 
had higher levels of FG (Razak et al. 2005) or were at excess risk for diabetes (Kondalsamy-
Chennakesavan et al. 2008) or had higher prevalence of diabetes (Huxley et al. 2008) at any 
given level of BMI or WC. Similarly, Filipino women living in the USA had much higher risk 
of diabetes at every level of visceral adipose tissue compared with White or African American 
women and the excess risk was not explained by visceral adipose tissue (Araneta and Barrett-
Connor 2005).  
 
With regard to the strength of association of anthropometric measures with diabetes 
incidence, a stronger association with BMI was observed in Asians or Chinese than in 
Caucasians of Australia (Ni Mhurchu et al. 2006) and the USA, but a similar association 
between Chinese and American Blacks (Stevens et al. 2008). The stronger association of 
diabetes with WHR or BMI in Caucasians than in Asians was, however, observed in a meta-
analysis (Vazquez et al. 2007) and OAC (Huxley et al. 2008).  
2.3 Obesity and hypertension 
2.3.1 Definition, prevalence and secular trend in hypertension 
High blood pressure or hypertension is defined by the presence of a chronic elevation of 
arterial blood pressure as systolic and/or diastolic blood pressure of 140/90 mm Hg and/or 
drug use for lowering blood pressure (WHO 1999; Giles et al. 2009). The prevalence of 
hypertension was very high worldwide and varied greatly among populations: highest in 
Europeans, Blacks (the USA) and North Chinese; intermediate in Whites from Australia, the 
UK and the USA, Hong Kong Chinese, Filipinos, Mongolians, Africans, Mexicans, Japanese, 
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and Chinese (Taiwan); and lowest in Indians, Canadians and Thais. Generally, the prevalence 
was higher in men than in women of most populations. The trend in hypertension prevalence 
increased for North Chinese, Blacks and White women (the USA), slightly decreased in 
Chinese (Taiwan) and was stable in Finns and Whites (the UK).  
 
As shown in Table 4, in Africans (Steyn et al. 2001; Bovet et al. 2002; Kamadjeu et al. 2006; 
Longo-Mbenza et al. 2008) the prevalence of hypertension was lower than in Blacks from the 
USA (Cutler et al. 2008). The prevalence of hypertension was much higher (50.0%) in 
Qingdao City of Northeast China (Ning et al. 2009) than that reported in a national survey 
(18.0%) (Wu et al. 2008). The prevalence of hypertension ranged from 18.0% to 26.0% in 
women and about 30.0% in men of Chinese (Hong Kong and Taiwan) (Su et al. 2008), 
Mongolian, Filipino, and Japanese ethnicities (Martiniuk et al. 2007) and was 22.0% in Thais 
(Aekplakorn et al. 2008). For Indians, the prevalence was estimated at 25.0% in urban and 
10% in rural areas by pooling results from epidemiological studies carried out in different 
regions (Gupta 2004). Approximately 22.0% of Canadians (Joffres et al. 1997), 26.0 - 33.0% 
of Whites from Australia (Briganti et al. 2003) and the UK (Falaschetti et al. 2009), Mexicans 
from Mexico (Barquera et al. 2008) and the USA (Cutler et al. 2008), and 35.0 - 60.0% of 
Europeans (Banegas et al. 1998; Cooper et al. 2005; Gabriel et al. 2008; Kastarinen et al. 
2009) and Blacks (the USA) had hypertension.   
 
Hypertension decreased from 1972 to 2002, but from 2002 to 2007 the decline levelled off in 
the FINRISK surveys (Vartiainen et al. 2010). Similarly, no increase in hypertension was 
reported in the UK between 2003 and 2006 (Falaschetti et al. 2009). However, in mainland 
China, the prevalence of hypertension increased from 11.0% in 1991 (Ueshima et al. 2000) to 
20.0% in 2002 (Wu et al. 2008), and even more of increase was reported in Qingdao City, 
China between 2002 and 2006 (Ning et al. 2009). The prevalence of hypertension increased in 
the USA between 1988 - 1994 and 1999 - 2004, with a higher increase in Blacks and in 
women of all three ethnic groups (Cutler et al. 2008). 
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Table 4 Adult prevalence of hypertension (%) 
 
Ethnicity, 
country, age range 
Study and year Men Women Total Reference 
African      
Cameroon*, ≥ 15 yr 
 
Cameroon Burden of 
Diabetes Survey 2003 
25.6 23.1  (Kamadjeu et al. 
2006) 
Congo*, ≥ 15 yr WHO STEPwise 2004    15.2 (Longo-Mbenza et 
al. 2008) 
Tansania*, 35-64 yr Dar es Salaam, 1998 27.1 30.2  (Bovet et al. 2002) 
South Africa*, 
 ≥ 15 yr 
Demographic and Health 
Survey 1998 
23.5 25.0 24.4 (Steyn et al. 2001) 
The USA*, ≥ 18 yr NHANES 1999-2004 39.1 40.8  (Cutler et al. 2008) 
Asian      
Chinese, China*,  
≥ 18 yr 
China National Nutrition 
and Health Survey 2002 
20.0 17.0 18.0 (Wu et al. 2008) 
Chinese, China,  
35-74 yr 
Qingdao Diabetes Survey 
2006 urban  
61.2 49.4  (Ning et al. 2009) 
 Qingdao Diabetes Survey 
2006 rural 
56.2 50.5   
Chinese, Hong Kong, 
≥ 15 yr 
Hong Kong Population 
Health Survey 2003-2004 
30.0 25.0  (Martiniuk et al. 
2007) 
Chinese, Taiwan*, 
≥ 19 yr 
Nutrition and Health 
Survey in Taiwan, 1993-96 
28.3 25.3 26.8 (Su et al. 2008) 
Chinese, Taiwan*, 
 ≥ 19 yr 
Taiwanese Survey on 
Hypertension, 
Hyperglycemia, and 
Hyperlipidemia 2002 
27.1 20.2 23.5 (Su et al. 2008) 
Japanese, Japan*, 
 ≥ 15 yr 
National Nutrition Survey 
2000 
28.4 18.0  (Martiniuk et al. 
2007) 
Indian, India Pooled studies 25.0 10.0  (Gupta 2004)  
Mongolian, 
Mongolia, 15-64 yr 
WHO NCD Survey 2005 30.0 26.1 28.1 (Bolormaa et al. 
2008) 
Filipino, Philippines*, 
≥ 20 yr 
5th National Nutrition 
Survey 1998 
30.0 24.0  (Martiniuk et al. 
2007) 
Thai, Thailand*, 
≥ 15 yr 
Third National Health 
Examination Survey 2004 
23.3 20.9 22.0 (Aekplakorn et al. 
2008) 
European/Caucasian      
Australia, ≥ 25 yr Australian Diabetes, 
Obesity, and Lifestyle 
  28.6 (Briganti et al. 
2003) 
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Study 1999-2000 
The UK, ≥ 16 yr Health Survey for England 
2006 
32.0 29.0 30.0 (Falaschetti et al. 
2009) 
Finland, 25-64 yr FINRISK study 2007    (Kastarinen et al. 
2009) 
 North Karelia 53.4 39.9   
 Northern  Savo 55.3 35.8   
 South-western Finland 47.3 25.4   
Germany, 35-64 yr National Health Survey 
1998  
60.2 50.4 55.3 (Cooper et al. 
2005) 
Italy, 35-64 yr National Survey 1998 48.0 35.1 41.5 (Cooper et al. 
2005) 
Spain*, 35-64 yr National Health Survey 
1990 
46.2 44.3 45.1 (Banegas et al. 
1998) 
Spain, ≥ 20 yr Pooled studies 1992-2001   38.0 (Gabriel et al. 
2008) 
Mixed, Canada*, 
20-79 yr 
Ontario Survey on 
Prevalence and Control of 
Hypertension 2006 
23.8 19.0 21.3 (Leenen et al. 
2008) 
Canada, 18-74 yr Canadian Heart Health 
Survey 1992 
26.0 18.0 22.0 (Joffres et al. 
1997) 
The USA*, ≥ 18 yr NHANES 1999-2004 27.5 26.9  (Cutler et al. 2008) 
Mexican      
Mexico, 25-64 yr National Health Survey 
(ENSA) 2000 
  33.0 (Barquera et al. 
2008) 
The USA*, ≥ 18 yr NHANES 1999-2004 26.2 27.5  (Cutler et al. 2008) 
*age-standardized rates otherwise crude  
 
 
 
 
 
 
 
31 
 
2.3.2 Major risk factors for hypertension  
In addition to genes, age and family history (Hunt et al. 1991; Wolf et al. 1997), there are 
other lifestyle-related risk factors for hypertension such as excess salt and alcohol intake 
(Dahl et al. 1958; INTERSALT Cooperative Research Group 1988; Brown et al. 2009), low 
potassium (Bussemaker et al. 2010), smoking and certain dietary factors (Appel et al. 2009), 
all of which probably contribute to hypertension. In a recent review, the mean sodium intake 
was > 100 mmol/day in most adult populations and > 200 mmol/day in Asian populations, 
both of which are far more than the recommended daily dose for salt (Brown et al. 2009). In 
European and North American countries, sodium intake dominated primarily from 
manufactured food, while in China and Japan, salt added in cooking and soya sauce were the 
largest sources. Alcohol intake increased blood pressure in a meta-analysis, in which alcohol 
dehydrogenase 2 polymorphism served as a surrogate measure of alcohol consumption (Chen 
et al. 2008).   
2.3.2.1 Obesity as a major risk factor for hypertension  
Obesity is a well-known modifiable risk factor for hypertension (Wolf et al. 1997; Huang et 
al. 1998; Mikhail et al. 1999; Brown et al. 2000; Pang et al. 2008). In the large prospective 
Nurse’s Health Study, obese women were at higher risk of developing hypertension: 2-fold in 
the BMI group of 24.0 - 24.9 kg/m
2
 and 6-fold in the 31.0 kg/m
2
 category than the group with 
BMI of < 20.0 kg/m
2
. Weight loss of 5.0 - 9.9 kg reduced the risk of developing hypertension 
by 15% while weight gain of 2.1 - 4.9 kg increased the risk by 29% compared with the group 
with stable weight (weight change ≤ 2 kg) (Huang et al. 1998). Similar findings were 
observed in Chinese individuals (Pang et al. 2008). The prevalence of hypertension 
progressively increased with increasing BMI and age in the WHO MONICA project and the 
NHANES III study (Wolf et al. 1997; Brown et al. 2000). Meta-analysis of 25 randomized 
intervention trials showed a net weight loss of 5 kg with energy restriction or increased 
physical activity or with both systolic blood pressure reduced by 4.4 mm Hg and diastolic 
blood pressure by 3.6 mm Hg (Neter et al. 2003), which was consistent with findings from 
other intervention trials (Stevens et al. 2001b; Appel et al. 2003; McGuire et al. 2004; Svetkey 
et al. 2005; Elmer et al. 2006; Bosworth et al. 2007; Bavikati et al. 2008; Cook et al. 2009). 
Follow-up of these intervention studies has shown the sustained effect of lifestyle 
interventions on hypertension (Elmer et al. 2006), coronary heart disease and stroke risk 
(Cook et al. 2007; Cook et al. 2009).  
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2.3.3 Comparison of BMI with measures of central obesity in relation to hypertension  
There is inconsistent evidence on which of the anthropometric measures of obesity (BMI or 
central obesity measures) is more strongly associated with hypertension, based on both 
prospective and cross-sectional studies. Furthermore, the prevalence of hypertension 
decreased or levelled off in some populations, but at the same time obesity has increased. This 
paradox needs further investigation, based on longitudinal studies.  
 
A number of studies have compared BMI with WC or WHR in relation to the incidence or 
prevalence of hypertension in adults (8 prospective and 21 cross-sectional). None of the 
prospective studies used formal statistical tests for their comparisons and the results were 
inconsistent: in favour of WC in Brazilian (Fuchs et al. 2005) and African Caribbean 
(Nemesure et al. 2008), but in favour of BMI in Greek adults (Panagiotakos et al. 2009) and 
Caucasian women from the USA (Shuger et al. 2008), while no difference was found in other 
studies (Folsom et al. 2000; Woo et al. 2002; Chuang et al. 2006). Among the cross-sectional 
studies, only seven formally tested the difference between BMI and measures of central 
obesity in association with hypertension and the findings were also inconsistent: WC or WSR 
was significantly better than BMI in Guadeloupean women (Foucan et al. 2002), multi-ethnic 
population from the USA (Menke et al. 2007), Chinese men (Zhou et al. 2009) and men in a 
meta-analysis (Lee et al. 2008a). However, BMI was significantly better than WHR or other 
central obesity measures in Asians (Huxley et al. 2008), Chinese women (Zhou et al. 2009) 
and Mexican women (Neufeld et al. 2008), but no differences between these measures were 
observed for women in a meta-analysis (Lee et al. 2008a) and Caucasians in the OAC 
(Huxley et al. 2008). Similar inconsistencies were also noted in studies in which formal tests 
were not done (Kroke et al. 1998; Berber et al. 2001; Okosun et al. 2001; Dalton et al. 2003; 
Ito et al. 2003; Esmaillzadeh et al. 2004; Grievink et al. 2004; Sung and Ryu 2004; Thomas et 
al. 2004; Wildman et al. 2005; Yalcin et al. 2005; Ghosh and Bandyopadhyay 2007; Wang 
2007; Abolfotouh et al. 2008; Huxley et al. 2008; Kaur et al. 2008; Uhernik and Milanovic 
2009).  
2.4. Obesity in the pathogenesis of diabetes and hypertension  
Obesity as a major contributor in the pathogenesis of diabetes and hypertension has been 
studied intensively in the last decade, but the underlying mechanism is still not clear. Most 
obese people are insulin-resistant (Ferrannini et al. 1997) and develop hypertension (Must et 
al. 1999). The hypotheses or candidate mechanisms of obesity in the pathogenesis of 
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metabolic disorders were reviewed extensively by our group (Qiao et al. 2007) and are 
summarized in Figure 2 and Figure 3.  
2.4.1 Obesity and insulin resistance 
Both abdominal visceral and subcutaneous fat contribute to obesity-related insulin resistance, 
and the data on the relative importance of these two fat depots are conflicting and require 
future investigation. A number of studies reported that visceral fat is more detrimental than 
other fat depots for type 2 diabetes (Despres et al. 1989; Lebovitz and Banerji 2005; Fox et al. 
2007; Kuk et al. 2008; Lee et al. 2008b; Gallagher et al. 2009; Hanley et al. 2009; Ledoux et 
al. 2010), due to more metabolic activity (Smith 1985; Trayhurn and Beattie 2001) and high 
rates of lipolysis (Smith 1985; Bjorntorp 1990; Arner 2002; Yang et al. 2008). An increased 
release of nonesterified fatty acids (NEFAs) from visceral fat through the portal circulation to 
the liver (Ferrannini et al. 1983; Bjorntorp 1990; Gastaldelli et al. 2007), as in the portal 
hypothesis (Figure 2), increased release of NEFAs into the systemic circulation from 
subcutaneous fat (Abate et al. 1995; Abate et al. 1996; Goodpaster et al. 1997; Frayn 2000; 
Chandalia et al. 2007) or inflammatory cytokines released from visceral fat (Hyatt et al. 2009) 
were considered as the link between visceral obesity and insulin resistance. A recent review 
by Taylor (Taylor 2008) suggested that gastric banding (Sjostrom et al. 1999; Carroll et al. 
2009) or bypass (Sjostrom et al. 1999; Dixon 2009) surgeries in extremely obese individuals 
improved or reversed insulin resistance and diabetes, due to visceral fat reduction (Carroll et 
al. 2009), including in dogs (Lottati et al. 2009).   
 
Overexpression of tumour necrosis factor alpha (TNF-α) in adipose tissue of rodents 
(Hotamisligil et al. 1993) and humans (Hotamisligil et al. 1996a; Hotamisligil et al. 1996b) 
provided the first clear link between obesity, diabetes and chronic inflammation. In the 
inflammatory hypothesis (Pickup et al. 1997; Pickup and Crook 1998; Clement et al. 2004; 
Ruge et al. 2009), large adipocytes infiltrated by macrophages (Takahashi et al. 2003; 
Weisberg et al. 2003; Xu et al. 2003; Lacasa et al. 2007) produced TNF-α and interleukin-6 
(IL-6) in obese individuals (Weisberg et al. 2003; Xu et al. 2003). These cytokines increased 
lipolysis in adipose tissue (Figure 2) (Goossens 2008), inhibited insulin receptor signalling 
through different pathways (Hirosumi et al. 2002; Rask-Madsen et al. 2003; Ozcan et al. 
2004; Hotamisligil 2005; Plomgaard et al. 2005; Krogh-Madsen et al. 2006; Bluher et al. 
2009; Chavey et al. 2009; Gregor et al. 2009; Monroy et al. 2009), and inhibited a 
differentiation of preadipocytes into mature adipocytes (Wu et al. 1999; Gustafson and Smith 
2006; Hotamisligil 2006; Rosen and MacDougald 2006; Isakson et al. 2009), all of which 
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finally led to insulin resistance. The role played by these inflammatory cytokines in obesity-
related insulin resistance is still under intensive investigation. 
In endocrine hypothesis, adipocytes secrete adipokines such as leptin and adiponectin, which 
act at both the local and systemic (endocrine) level (Mohamed-Ali et al. 1998; Trayhurn and 
Beattie 2001; Goossens 2008; Karastergiou and Mohamed-Ali 2010). Current evidence for 
high leptin (or leptin resistance) and low adiponectin in obesity-related disorders is not clear 
and needs further investigation. High leptin levels increased the risk of diabetes in men and 
women (Schmidt et al. 2006) or only in men (McNeely et al. 1999; Soderberg et al. 2007) and 
the risk was reduced once it was adjusted for body fat and inflammation (Schmidt et al. 2006). 
In the endocrine hypothesis, leptin inhibits insulin secretion (Emilsson et al. 1997; Kieffer et 
al. 1997; Maedler et al. 2008) or impairs insulin-mediated glucose uptake in obese individuals 
(Hennige et al. 2006). Exposure of human islets to high levels of leptin and glucose resulted 
in β-cell apoptosis (Maedler et al. 2008), but an experimentally induced hyperinsulinaemia 
had no effects on leptin (Ruge et al. 2009).  
 
Adiponectin levels were decreased in diabetes (Hotta et al. 2000; Weyer et al. 2001) and 
obesity (Arita et al. 1999; Weyer et al. 2001), due to inhibition of their synthesis by TNF-α 
and other cytokines. Low adiponectin showed decreased anti-inflammatory effect (Chandran 
et al. 2003; Devaraj et al. 2008; Ouchi and Walsh 2008) and insulin sensitivity in skeletal 
muscle (Stefan et al. 2002b), liver (Stefan et al. 2003), and in whole-body in Pima Indians 
(Stefan et al. 2002b), and increased hepatic glucose production in mice (Yamauchi et al. 
2002). It also inhibited glucose utilization and fatty acid oxidation (Yamauchi et al. 2002; 
Chandran et al. 2003; Redinger 2008), but in nondiabetic Pima Indians and Whites, plasma 
adiponectin was not associated with fatty acid oxidation under resting conditions (Stefan et al. 
2002a). 
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Insulin sensitivity ↓      Insulin resistance 
Islet β-cell insulin secretion      Hyperglycemia 
Glucose uptake and utilization by the cells ↓   Impaired glucose tolerance 
Liver gluconeogenesis and glycogenolysis ↑ 
Portal hypothesis 
Visceral fat ↑              Blood NFFA flux ↑   
   Blood triglyceride ↑ Liver VLDL production ↑                                                                  
HDL-c ↓       Dyslipidemia 
      Small and dense LDL particle ↑      NAFLD  
                                                                           Non-adipose tissue lipid deposit ↑                                                     Insulin resistance        
                                                            
          Adipose lipolysis ↑                        FFA ↑ 
Inflammatory hypothesis   Adipose insulin action ↓        c-JNK pathway  
TNF-α and IL-6 ↑                                                      Ask1-MKK4-MAPK/JNK ↑,                   
                                                                                            Ask Substrate 160 ↓, or  
                                                                                            TACE/TIMP3 dysregulation           Lipid deposition           Insulin resistance 
 CXC 5                                                                            Jak2/STAT5/SOCS2 ↑                   in non-adipose             Low grade inflammation        
        Preadipocyte differentiation↓   PPARγ and CCAAT/EBPα ↓                 
                                                                                            Wnt10b signalling ↑  
                                                                                            MAP4K4               ↑                                 
                                               Other inflammation mediator factors production ↑                   
                                    
Endocrine hypothesis  
Adiponectin ↓  Anti-inflammation effect ↓                TNF-α, IL-6, and CRP ↑ 
   Insulin sensitivity ↓                          Tyrosine phosphorylation of IR ↓    
                                       Glucose utilization↓                 
                                       FA oxidation         ↓                         Phosphorylation of IR  
                                       Hepatic gluconeogenesis ↑             with AMP protein kinase↓                                                      
                                                                                                                                                                           Insulin resistance  
Leptin ↑    β cells insulin secretion ↓                  ATP-sensitive K+ channels ↑  
or leptin resistance          β cells apoptosis  ↑                          JNK pathway activation ↑ 
                                        Glucose uptake    ↓                           Phosphorylation of IRS-1↓     
 
 
Figure 2 Role of obesity in insulin resistance or diabetes (Qiao et al. 2007) 
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2.4.2 Obesity and hypertension  
The precise role of leptin and insulin as well as the sympathetic nervous system (SNS) needs 
to be clarified in obesity-associated hypertension. Activation of the SNS was increased in 
obesity (Tuck 1992; Esler 2000; Alvarez et al. 2002). Studies have shown that weight loss 
decreased SNS activation, which was correlated with decrease in blood pressure (Sowers et 
al. 1982; Tuck et al. 1983; Tuck 1992), but not as a sufficient cause (Esler 2000). The 
activation of SNS increased blood pressure by activating the renal SNS to facilitate sodium 
reabsorption (Mikhail et al. 1999; Hall 2000; Bogaert and Linas 2009), as shown in Figure 3.  
 
 
Na+ reabsorption in kidney↑          Antinatriuresis    
  
                                                                                                                           Hypertension 
 SNS ↑                                                                                    
                                   
Leptin secretion ↑            SNS activity ↑  
    in the kidney and heart                                                                                         
Adipose tissue                                                                                                          
RAS activation ↑                      AGT production ↑                                                  Hypertension                
                                                 Angiotensin II     ↑  
                                                                                                  
                                          Na+ retention ↑  
                                          SNS ↑ 
Hyperinsulinemia        Insulin induced NO production ↓        vasodilatation ↓ 
                                          Insulin induced endothelium 
                                          ET-1 production   ↑                          vasoconstriction↑  
 
 AGT-angiontensinogen, ET-1 endothelin-1, NO nitric oxide, RAS-Renin angiotensin system, SNS 
Sympathetic nervous system  
 
 
Figure 3 Role of obesity in obesity-associated hypertension (Qiao et al. 2007) 
 
 
Since 2000, leptin has been considered to increase arterial pressure through activation of the 
SNS in kidney and heart (Haynes 2000; Carlyle et al. 2002; Correia and Haynes 2004; Prior et 
al. 2010). However, the results from association studies in humans were inconsistent. Some 
investigators demonstrated that leptin levels predicted hypertension incidence in Italian males 
(Galletti et al. 2008) or were positively associated with blood pressure (Aizawa-Abe et al. 
2000; Ma et al. 2009; Nakamura et al. 2009), while no association was found in a Swiss 
population (Suter et al. 1998). 
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Addipose tissue derived angiotensin II and angiotensiongen have been considered as possible 
links between obesity and hypertension independent of the systemic renin angiontensin 
system (Goossens et al. 2003), but the effect of these components on blood pressure in 
humans is still not clear (Prat-Larquemin et al. 2004).   
 
Hyperinsulinaemia was closely associated with hypertension (Lucas et al. 1985; Ferrannini et 
al. 1987). Insulin has both vasodilative and vasoconstrictive effects on the endothelium (Jonk 
et al. 2007), with the net effect depending on these two. Insulin stimulates activation of the 
SNS (Anderson et al. 1991; Savage et al. 1998) and enhances sodium retention (DeFronzo 
1981; Mikhail et al. 1999; Mikhail and Tuck 2000). However, there have been conflicting 
results, since insulin’s vasodilatory effect was blunted in obesity (Laakso et al. 1990; Mikhail 
2009), while others (Savage et al. 1998) did find a difference in insulin-mediated forearm 
blood flow between two groups of hypertensive individuals in the upper and lower tertiles of 
insulin sensitivity.  
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3. AIMS OF THE STUDY 
 
The overall aims of the study were to compare the predictive values of various anthropometric 
measures of obesity with undiagnosed or newly diagnosed type 2 diabetes and hypertension, 
to identify the cut-off/change point values for BMI and WC in different populations and to 
explore ethnic differences in these associations. 
 
The specific objectives of the study were:  
 
1. To compare BMI with central obesity measures in relation to diabetes and 
hypertension in populations of Asian origin (I), 
2. To compare BMI with WC, WHR and WSR as predictors of hypertension (II) and 
diabetes (III) incidence in Mauritius,   
3. To evaluate ethnic-specific WC cutoff values for central obesity in the metabolic 
syndrome proposed by the IDF in 2005 and its comparison with the NCEP definition 
(IV). 
4. To explore ethnic differences in the association of undiagnosed diabetes with obesity 
within the large DECODA and DECODE studies, using standardized methods (V) and            
5. To identify the change point values for BMI and WC for the presence of undiagnosed 
diabetes in different ethnic groups within the large DECODA and DECODE studies, 
using Bayesian analysis (VI submitted to International Journal of Obesity). 
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4. POPULATIONS AND METHODOLOGY 
 4.1 Study population 
The DECODA/DECODE 
(http://ktlwww.ktl.fi/deco/decoda/index.html/http://ktlwww.ktl.fi/deco/decode/index.html) 
studies were initiated by the International Diabetes Epidemiology Group and European 
Diabetes Epidemiology Group in 1998 and 1997, respectively. They consist of population- or 
community-based or large occupational studies from Asia, Europe, Brazil and Mauritius with 
63 633 study individuals (Figure 4 and Figure 5), creating one of the largest epidemiological 
databases in the world on studies of glucose intolerance, obesity and metabolic syndrome. 
Researchers who had carried out epidemiological studies of diabetes and impaired glucose 
regulation, using a standard 2-h 75-g oral glucose tolerance test (OGTT) were invited to 
participate in the DECODA/ DECODE Studies (Qiao et al. 2000; The DECODA Study Group 
2003; The DECODE Study Group 2003). Collaborative data analysis was coordinated in the 
National Institute for Health and Welfare and the Department of Public Health, University of 
Helsinki, Helsinki, Finland.   
According to the specific aims of the articles, various inclusion criteria were set up and 
described in each article. Briefly, data from 16 participating cohorts in the DECODA study 
with a 9095 men and 11 732 women 35-74 years of age, from seven countries of Asia, were 
included in the study population (I). The inclusion criteria for the current data analysis were 
1) cohorts with all four anthropometric measures for obesity and 2) data on FPG and 2-h PG 
(not for Filipino and Mongolian studies), as well as systolic and diastolic blood pressure. A 
total of 14 222 nondiabetic and 1516 diabetic subjects from nine cohorts in the DECODA 
study, 25 - 74 years of age, with required variables for metabolic syndrome, comprised the 
study population (IV). The study population (V, VI) comprised 25 250 men and 30 788 
women, ≥ 30 years of age, from 34 cohorts in the DECODA and DECODE studies of 11 
countries in Asia and Europe. The inclusion criteria of the cohorts were as follows 1) cohorts 
with anthropometric measures for both BMI and WC (except for Japanese cohorts), 2) data on 
both FPG and 2-h PG (for subgroups of individuals in the FINRISK study), 3) individuals 30 
years of age or over and 4) population-based studies with random sampling. Individuals with 
prior history of diabetes and hypertension were excluded because treatment for diabetes (or 
hypertension) and duration of the disease could affect weight and WC.  
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Figure 4 DECODA Study Population     
*occupational-study otherwise population-based, for full study names see table 5 
D 
E 
C 
O 
D 
A 
BRAZIL 
CHINA 
 
JAPAN 
INDIA 
MONGOLIA 
MAURITIUS 
PHILIPPINES 
São Paulo 1992-93, n = 346, and 86 
São Paulo 1999-00, n = 546, and 80  
 
*HKwscvdrf 1991, n = 871, and 
69/50 in company/hospital 
HKcvrfps
 
1995, n = 2439, and 38  
Beijing Study 1997, n = 1401, and 
98  
 
Shunyj Study 1997, n = 1109, and 
98 
Qingdao 2002, n = 1796, and 83 
 
Qingdao 2006, n = 3230, and 90 
 
Funagata 1990, n = 2506, and 65 
Funagata 1995, n = 2034, and 58 
Hisayama 1988, n = 2289, and 96 
Ojika 1991, 1996, n = 213, and 47  
Chennai 1994, n = 1112, and 84 
 
Mongolia 1999, n = 1991, and 94 
CUPS 1997, n = 773, and 90 
NUDS 2000, n = 7418, and 90 
CURES 2004, n = 1600, and 90 
Chennai 2006, n = 2634, and 86 
Mauritius 1987, n = 2519, and 86 
Mauritius 1992, n = 1270, and 90 
Mauritius 1998, n = 716, and 87 
Philippines 2001, n = 3841, and 70 
Studies, year, sample size, and response 
rate (%)        
Countries 
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Figure 5 DECODE Study Population 
D 
E 
C 
O 
D 
E 
CYPRUS 
FINLAND 
 
ITALY 
SWEDEN 
 
SPAIN 
NETHERLAND 
THE UNITED  
KINGDOM 
Nicosia Study 2003, n = 946, and 
76  
 
FINRISK 1987, n = 2688, and 79 
FINRISK
 
1992, n = 1859, and 77 
 
FINRISK 2002, n = 3583, and 71  
 
Savitaipale 1997, n = 1102, and 
77 
Cremona 1990, n = 1662, and 58 
Viva Study 1996, n = 1938, and 
93 
MONICA 1986, n = 550, and 82 
MONICA 1990, n = 696, and 81 
MONICA 1994, n = 883, and 77 
MONICA 2004, n = 827, and 76 
Hoorn Study 1990, n = 2371, and 
71 
Ely Study 1990, n = 1108, and 74 
Newcastle Heart, n = 766, and 96 
Studies, year, sample size, and response 
rate (%)        
Countries 
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The Mauritius noncommunicable disease surveys 
Mauritius is an island in the Indian Ocean, with a population in 1987 of about 1.2 million, 
comprising about 70% Mauritian Indians, 2% Chinese and 28% Creoles (predominantly of 
African and Malagasy ancestry with some European admixture, referred to as Mauritian 
Creoles). Population-based surveys for prevention and control for chronic noncommunicable 
disease were conducted in 1987, 1992, and 1998, respectively, using similar study protocols 
and procedures (Soderberg et al. 2005; Soderberg et al. 2007). In 1987 at baseline, all adults 
25 - 74 years of age living within 10 randomly selected, geographically defined areas of 
Mauritius were invited to the survey. In 1992 and 1998, the same clusters were invited for re-
examination, with three new clusters added in 1992. According to the dates of entry into (free 
of diabetes or hypertension) and exit (diabetes or hypertension diagnosis) from the study, 
participants were divided into four cohorts with follow-up periods of 5, 6 or 11 years, 
respectively, as shown in Figure 6.  
Figure 6 Mauritius noncommunicable disease surveys
The inclusion criteria for hypertension incidence (II) were 1) individuals with all four 
anthropometric indicators for obesity and 2) data on systolic and diastolic blood pressure, 
lipids, ethnicity, alcohol use and smoking status. Individuals with known and newly 
diagnosed hypertension, CVD, gout, pregnant women and missing data for age, lipids and 
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smoking status at baseline were excluded. A total of 1658 men and 1976 women of Mauritian 
Indian and Mauritian Creole ethnicity were included in the analysis for anthropometric 
measures of obesity as predictors of hypertension incidence. The inclusion criteria for 
diabetes incidence (III) were 1) individuals with all four anthropometric indicators for obesity 
and 2) data on FPG and 2-h PG, lipids, blood pressure, alcohol use, smoking status, family 
history of diabetes and data on SES. Individuals with known and newly diagnosed diabetes, 
CVD, gout, pregnant women and missing data for required variables at baseline were 
excluded. A total of 1841 men and 2104 women of Mauritian Indian and Mauritian Creole 
ethnicities were included in the analysis for anthropometric measures of obesity as predictors 
of diabetes incidence.  
4.2 Survey methodology and physical examination 
4.2.1 Definition of clinical endpoints in the study  
 For individuals without previously diagnosed diabetes, undiagnosed or newly 
diagnosed diabetes was defined as FPG of ≥ 7.0 mmol/l or 2-h PG of  ≥ 11.1 mmol/l, 
following a 75-g OGTT, except for Mongolian and Filipino in which only 2-h PG 
alone was used (WHO Consultation 1999). Individuals who were free of diabetes in 
the previous survey but developed diabetes during the period between the surveys, or 
were tested positive in the subsequent survey, were counted as incident cases in the 
Mauritius surveys. 
 Hypertension was defined as systolic and /or diastolic blood pressure ≥ 140/90 mmHg 
or self-reported antihypertensive therapy according to the 1999 World Health 
Organization-International Society of Hypertension (WHO-ISH) guidelines (WHO 
1999). Individuals who were free of hypertension in the previous survey but 
developed hypertension during the period between the surveys, or were tested positive 
in the subsequent survey, were counted as incident cases in the Mauritius surveys.  
 The 2005 IDF definition requires central obesity as a mandatory component for 
diagnosis of the metabolic syndrome, using ethnicity-specific values plus any two of 
the four components below: 1) serum triglyceride ≥ 1.7 mmol/l 2) serum high-density 
lipoprotein (HDL) cholesterol < 1.03 mmol/l in men and < 1.29 mmol/l in women 3) 
systolic and/or diastolic blood pressure ≥ 130/85 mmHg, or treatment of previously 
diagnosed hypertension, regardless of the current blood pressure values and 4) FPG ≥ 
5.6 mmol/l or previously diagnosed type 2 diabetes (Alberti et al. 2005). IDF central 
obesity was defined as WC ≥ 90/80 cm for men/women of Chinese and Asian Indian 
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ethnicities ≥ 85/90 cm for Japanese men/women. The NCEP defines a person as 
having metabolic syndrome when three or more of the five components above, but 
using different positive cutoffs for FPG ( ≥ 6.1 mmol/l) and WC ( > 102 cm in men 
and > 88 cm in women) (Expert Panel on Detection 2001).  
4.2.2 Anthropometric measures for obesity and blood pressure measurements  
In all DECODA/DECODE studies, anthropometric measures were taken by trained observers 
and described in detail for each cohort in Appendix 3. In most of the studies, WC (cm) was 
measured at the midpoint between the lower margin of the ribs and the iliac crest, except for a 
few studies in which it was measured between the umbilicus and xiphoid process (two Hong 
Kong studies and Mauritius87) and at the umbilicus (Cremona, São Paolo, Funagata Diabetes 
studies). Hip circumference (cm) was measured over the greater trochanter in most of the 
studies and around the buttocks posteriorly and the symphysis pubis anteriorly in the 
Mauritius, São Paolo and Hong Kong Workforce studies. Weight and height were measured in 
light clothing without shoes.  
BMI was calculated as weight in kilograms divided by the square of the height in metre 
(kg/m
2
). WHR was calculated as WC divided by hip circumference. WSR was calculated as 
WC divided by the height in centimeters. Blood pressure was measured on the right arm of 
the participant, using a standard mercury sphygmomanometer, after the participant had been 
sitting for 5 – 10 minutes in all studies, except for São Paolo 99-00 survey, in which it was 
measured using an automatic device (Omron model HEM-712C, Omron Healthcare, 
Bannockburn, IL, the USA).  
In the Mauritius surveys, smoking status, alcohol use, ethnicity, family history of diabetes and 
data on SES as income and education levels (school years) were determined by self-reports 
from questionnaires.  
4.2.3 Laboratory Methods  
Blood samples were collected after overnight fasting for measurements of glucose and lipids. 
A 2-h 75-g OGTT was performed in all cohorts (except for Mongolians, Filipinos and for 
subgroup of individuals in the FINRISK study). PG was measured in most of the studies, with 
a few exceptions (Qiao et al. 2000; The DECODE Study Group 2003). Before the data were 
analysed, capillary and whole blood glucose were converted into PG according to the 
formulae described previously (Carstensen et al. 2008). Oxidase or dehydrogenase methods 
for glucose were used in all cohorts. Enzymatic methods for triglyceride and HDL cholesterol 
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were applied in the DECODA study cohorts. Detailed information on glucose and lipid assays 
for individual studies is presented in Appendix 3.  
4.2.4 Statistical Analysis 
The prevalence or incidence of diabetes, hypertension and central obesity was calculated, 
using descriptive statistics. Significant differences between Europeans and other ethnic 
groups were determined by Chi-squared (χ2) test for categorical variables and the F test for 
other continuous variables. For each obesity indicator, the squared terms were also tested to 
check whether the relationship with diabetes or hypertension was curvilinear. Meta-analysis 
using the method detailed by Fleiss (1993) was performed, based on the individual data of 16 
studies. A fixed effect approach was chosen, since Q statistics for measuring interstudy 
variation in effect size were not statistically different from zero for all obesity indicators of 
either diabetes or hypertension. Standard logistic regression analysis, adjusting for studies and 
age, was performed to estimate the OR for each of the obesity indicators, based on pooled 
data, ethnic groups and different subgroups. The hazard ratio (HR) for the development of 
diabetes and hypertension for each of the obesity indicators was estimated, applying Cox 
proportional hazard models to interval-censored data (Carstensen 1996; Hosmer and 
Lemeshow 1999), using age as a timescale. A series of population-based studies in Mauritius 
motivated use of interval-censored survival analysis, since the exact date for incidence of 
diabetes or hypertension was unknown but was known to lie between the three examinations. 
A paired homogeneity test (Wald statistics with 1df) was performed to test the equality of 
regression coefficients between BMI and each of the central obesity indicators of WC (BMI = 
WC), WHR (BMI = WHR) and WSR (BMI = WSR), using the Car and IC packages in the R-
program in both cross-sectional and prospective data analysis.  
 
Logistic regression analysis, adjusting for age, was also performed to estimate the  
coefficient corresponding to sex- and study-specific one standard deviation (SD) increase in 
BMI or WC (the slope of the regression line or the strength of the association of diabetes with 
BMI or WC) for the presence of diabetes in each ethnic group. The homogeneity test with a 
null hypothesis that the  coefficients are the same between ethnic groups was performed, 
using the method of Fleiss.  
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Hierarchical three-level Bayesian change point analysis, adjusting for age, was applied to 
obtain the most likely values for the BMI or WC categories with respect to the changes in 
prevalence of undiagnosed diabetes. The model parameters, such as mean change points and 
prevalence before and after the change point were obtained, using OpenBugs (Thomas et al. 
2006) software and packages BRugs and Coda in the R-program (Ihaka and Gentleman 1996), 
with 10 000 burn-in iterations followed by 50 000 iterations. Convergence was assessed using 
the Geweke-statistic. ROC curve analysis was performed to determine the optimal cutoff 
values for BMI and WC with undiagnosed diabetes. The sensitivity and specificity was 
calculated at the optimal cutoff values for BMI and WC. Statistical analyses were carried out, 
using SPSS for Windows (versions 14 and 15) and the R-program (version 2.4.1, 2.6.0 and 
2.8.1).  
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5. RESULTS 
5.1 Comparison of BMI with central obesity measures in relation to diabetes 
and hypertension, based on cross-sectional (I) and prospective study (II, III) 
5.1.1 Characteristics of the DECODA study population 
In general, Mongolians had a higher mean BMI of 25 - 26 kg/m
2
 and WC of 87 - 88 cm than 
other ethnic groups (Table 5). The mean WC was 5 cm higher for Chinese, Japanese, Asian 
Indian and Mauritian Indian men than for women, but were similar in Mongolians and 
Filipinos. The crude prevalence (total) of undiagnosed diabetes ranged from 9.5% to 12.6% 
among Asian Indians living in India and Mauritius, from 4.7% to 10.2% in Japanese, Filipinos 
and Chinese and about 2.0% in Mongolians. Hypertension was most common among Chinese 
(north only), Mongolians, Filipinos and migrant Japanese. 
 
In the Mauritius survey, a total of 787 and 628 incident cases of hypertension and diabetes 
developed during the follow-up periods (Table 6). The incidence of hypertension was slightly 
higher in Mauritian Creoles than in Mauritian Indians and was similar between men and 
women for a given ethnic group. Individuals who developed diabetes or hypertension were 
older, more obese, had a higher blood pressure (not for Creole women) and poorer lipid 
profile than those who remained nondiabetic or normotensive. Smoking habits were similar 
between people who did or did not develop diabetes or hypertension, but were higher in 
Mauritian Creole women than in Mauritian Indian women.  
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Table 5 Characteristics of the DECODA study cohorts 
 Men      Women      
 Mean 
age (range)   
Number 
of 
subject 
BMI 
(kg/m
2
) 
Waist  (cm) 
 
DM 
(%) 
HT 
(%) 
Mean 
age (range) 
Number 
of 
subject 
BMI 
(kg/m
2
) 
Waist (cm) DM 
(%) 
HT 
(%) 
Chinese  52 (30-89)
a
 4651 25.2 (0.05)
a
 86.6 (0.15)
a
 10.2
a
  51 (30-89)
a
 6195 25.4 (0.05)
a
 81.5 (0.12)
a
 10.2
a
  
HKcvrfps
b
 48(30-74)  1188 24.3 (0.11) 83.5 (0.29) 7.5 15.5 46 (30-74) 1251 24.3 (0.12) 76.6 (0.31) 7.0 11.5 
HKwscvdrf
c
 42 (35-62) 489 23.5 (0.15) 82.2 (0.35) 4.9 21.7 43 (35-63) 382 24.2 (0.20) 77.5 (0.40) 4.2 6.0 
Beijing  58(40-88)  548 25.1 (0.16) 88.2 (0.44) 8.0 46.4 57 (40-89) 853 24.9 (0.15) 82.0 (0.37) 8.8 39.8 
Qingdao 
2002 
54(30-74) 670 26.6 (0.14) 89.9 (0.40) 10.9 49.4 53 (30-74) 1126 26.3 (0.13) 83.3 (0.32) 9.1 44.4 
Qingdao 
2006 
49 (30-87) 1311 25.7 (0.09) 87.4 (0.26) 15.2  49 (30-86) 1919 25.8 (0.08) 82.2 (0.21) 13.9  
Shunyj 55(40-88)  445 24.4 (0.17) 84.6 (0.48) 4.7 57.9 53 (40-84) 664  25.5 (0.17) 83.4 (0.42) 8.6 50.0 
Filipinos 48 (35-65) 1351 23.1 (0.11) 82.9 (0.25) 5.5 58.8 48 (35-65) 2490 23.8 (0.10) 81.8 (0.20) 5.9 42.6 
Japanese 58 (34-89)
a
       3426 23.2 (0.05)
a
  81.5 (0.36)
a
   6.0   58 (30-86)
a
   4508   23.6 (0.05)
a
   74.3 (0.33)
a
     4.7      
Funagata 
Study90-92 
59 (40-87) 1102 23.5 (0.11)  4.6  60 (40-86) 1404 23.7 (0.12)  5.4  
Funagata 
Study95-97 
58 (35-89)  863 23.6 (0.13) 81.0 (0.35) 4.3 14.2 58 (35-86) 1171 23.6 (0.51) 74.5 (0.32) 3.0 10.7 
Hisayama 56 (40-79) 962 22.9 (0.12)  8.8  57 (40-79) 1327 22.8 (0.12)  5.2  
Ojika 91,96 57 (34-73) 70 23.1 (0.32)  11.4  52 (30-80) 143 23.3 (0.28)  8.4  
Brazil, São 
Paulo 92-93 
55 (40-74) 174 24.2 (0.25) 85.6 (0.60) 2.3 28.2 56 (37-74) 172 23.9 (0.24) 83.2 (0.60) 2.9 28.5 
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Brazil, São 
Paulo 99-00 
54 (35-73) 255 25.2 (0.20) 87.5 (0.58) 27.8 51.0 53 (35-73) 291 24.2 (0.19) 78.3 (0.54) 21.3 41.9 
Mongolian 46 (35-74) 916 25.1 (0.14) 88.2 (0.30) 2.0 45.0 46 (35-74) 1075 26.4 (0.12) 86.5 (0.29) 2.0 30.3 
Asian 
Indian 
46 (30- 
102)
a
 
6176 23.0 (0.05)
a
 83.7 (0.14)
a
 12.6
a
  45 (30-99)
a
 7361 24.3 (0.06)
a
 81.3 (0.14) 12.0
a
  
Chennai94 45 (30-84) 587 22.4 (0.15) 83.9 (0.42) 8.7 23.5 44 (30-80) 525 23.9 (0.19) 80.8 (0.47) 12.4 25.4 
CUPS 1997 46 (30-82) 314 22.0 (0.21) 81.2 (0.57) 7.0 22.9 47 (30-87) 459 23.7 (0.20) 77.5 (0.51) 7.2 20.3 
NUDS 
2000 
46 (30-96) 3431 22.9 (0.07) 82.6 (0.19) 14.4  46 (30-99) 3987 24.2 (0.08) 80.8 (0.19) 13.9  
CURES 45 (30-102)  747 23.3 (0.13) 87.7 (0.37) 13.9 21.0 43 (30-80) 853 23.8 (0.15) 84.4 (0.37) 11.5 19.1 
Chennai 
2006 
43 (30-83) 1097 23.7 (0.11) 86.1 (0.31) 9.8  42 (30-85) 1537 25.6 (0.11) 85.4 (0.28) 8.5  
Mauritian 
Indian 
45 (30-82)
a
 2123 23.5 (0.08)
a
 82.2 (0.22)
a
 12.5
a
  45 (30-79)
a
 2382 24.9 (0.10)
a
 78.0 (0.24)
a
 9.5
a
  
Mauritius87 45 (30-74)   1191 22.7 (0.11) 78.4 (0.30) 11.7 25.5 45 (30-75) 1328 24.4 (0.12) 75.9 (0.30) 8.4 17.7 
Mauritius92 46 (30-72)  613 24.1 (0.15) 87.6 (0.41) 13.1 19.2 46 (30-74) 657 26.4 (0.17) 86.3 (0.42) 11.6 21.4 
Mauritius98 42 (30-82)  319 24.4 (0.21) 88.3  (0.57) 14.4 23.4 42 (30-79) 397 25.3 (0.22) 79.0 (0.55) 9.8 17.0 
Data are age adjusted mean (SE);  
DM and HT denote diabetes and hypertension prevalence; 
a 
difference compared to Europeans (p < 0.05) in table 8;  
b 
Hong Kong Cardiovascular Risk Factor Prevalence Study;  
c 
Hong Kong Workforce survey on CVD risk factors. 
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Table 6 Characteristics of the study population at baseline according to hypertension and diabetes status at the end of the follow-up 
Ethnicity Mauritian Indian Mauritian Creole Mauritian Indian Mauritian Creole 
 Non-
hypertension 
Hypertension Non-hypertension Hypertension Non-diabetes Diabetes Non-diabetes Diabetes 
Men, 
numbers 
 1002                            249 296 111  1116                            229 419 77 
Age (years) 38 (37-38) 43 (41-44) 38 (37-40) 42 (40-44) 38 (37-39) 43 (41-44) 40 (39-41) 43 (40-46) 
BMI (kg/m
2
) 22.6 (22.4-22.8) 23.8 (23.4-24.3) 22.5 (22.1-22.9) 23.5 (22.8-24.1) 22.6 (22.4-22.8) 24.9 (24.4-25.3) 22.7 (22.4-23.0) 25.5 (24.8-26.3) 
WC (cm) 78.9 (78.3-79.4) 81.6 (80.5-82.7) 77.1 (76.2-78.1) 80.1 (78.5-81.8) 78.6 (78.1-79.1) 84.3 (83.2-85.4) 77.9 (77.2-78.7) 85.0 (83.2-86.8) 
WHR 0.89 (0.88-0.89) 0.91 (0.90-0.91) 0.86 (0.86-0.87) 0.89 (0.88-0.90) 0.89 (0.88-0.89) 0.92 (0.91-0.93) 0.87 (0.87-0.88) 0.91 (0.90-0.92) 
WSR 0.48 (0.48-0.48) 0.50 (0.49-0.51) 0.46 (0.46-0.46) 0.49 (0.48-0.50) 0.48 (0.48-0.48) 0.51 (0.51-0.52) 0.47 (0.46-0.47) 0.51 (0.50-0.52) 
SBP (mm 
Hg) 
116 (115-116) 124 (122-125) 119 (118-120) 125 (123-126) 120 (119-121) 126 (124-128) 126 (124-127) 132 (128-135) 
DBP (mm 
Hg) 
72 (72-73) 77 (76-78) 74 (73-75) 78 (77-80) 75 (74-76) 79 (78-81) 78 (77-79) 81 (79-83) 
TC (mmol/l) 5.3 (5.2-5.4) 5.4 (5.2-5.7) 5.3 (5.1-5.4) 5.4 (5.2-5.7) 5.3 (5.2-5.4) 5.5 (5.3-5.7) 5.3 (5.2-5.5) 5.5 (5.1-5.8) 
TG 
(mmol/l)* 
1.35 (1.30-1.40) 1.46 (1.36-1.57) 1.15 (1.08-1.23) 1.42 (1.27-1.58) 1.31 (1.26-1.35) 1.83 (1.69-1.98) 1.22 (1.16-1.29) 1.75 (1.52-2.00) 
HDL 
(mmol/l) 
1.25 (1.23-1.27) 1.24 (1.19-1.29) 1.31 (1.27-1.36) 1.28 (1.21-1.35) 1.27 (1.25-1.29) 1.19 (1.14-1.24) 1.34 (1.30-1.38) 1.19 (1.09-1.28) 
Smokers % 60.8  59.0  68.9  75.7  58.4  58.8  72.1  74.0  
Women, 
numbers 
1174 296 375 131 1302 223 480 99 
Age (years) 38 (37-38) 46 (45-47) 39 (38-40) 45 (43-47) 39 (38-40) 43 (41-44) 41 (40-42) 48 (46-50) 
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BMI (kg/m
2
) 23.4 (23.1-23.6) 25.9 (25.4-26.5) 24.1 (23.6-24.5) 26.2 (25.3-27.0) 23.5 (23.3-23.8) 26.0 (25.4-26.6) 24.7 (24.3-25.1) 27.0 (26.1-28.0) 
WC (cm) 74.1 (73.5-74.6) 79.9 (78.6-81.1) 75.9 (74.9-76.9) 80.4 (78.5-82.3) 74.3 (73.8-74.9) 80.0 (78.4-81.1) 77.5 (76.6-78.4) 82.5 (80.4-84.5) 
WHR 0.81 (0.81-0.81) 0.83 (0.83-0.84) 0.81 (0.80-0.82) 0.83 (0.82-0.84) 0.81 (0.81-0.81) 0.84 (0.83-0.84) 0.82 (0.81-0.82) 0.84 (0.83-0.85) 
WSR 0.49 (0.49-0.50) 0.54 (0.53-0.55) 0.49 (0.49-0.50) 0.53 (0.52-0.54) 0.50 (0.49-0.50) 0.53 (0.52-0.54) 0.51 (0.50-0.51) 0.54 (0.53.-0.55) 
SBP (mm 
Hg) 
112 (112-113) 123 (122-124) 115 (114-116) 124 (123-126) 117 (116-118) 121 (119-123) 123 (122-125) 126 (123-130) 
DBP (mm 
Hg) 
69 (69-70) 75 (75-76) 71 (70-72) 77 (76-79) 72 (71-72) 73 (72-75) 75 (74-76) 77 (75-79) 
TC (mmol/l) 4.9 (4.9-5.0) 5.2 (5.1-5.4) 5.2 (5.1-5.4) 5.6 (5.3-5.8) 5.0 (4.9-5.1) 5.0 (4.9-5.2) 5.4 (5.3-5.5) 5.5 (5.2-5.8) 
HDL 
(mmol/l) 
1.34 (1.32-1.36) 1.29 (1.26-1.33) 1.34 (1.31-1.37) 1.26 (1.21-1.31) 1.35 (1.33-1.37) 1.26 (1.22-1.30) 1.36 (1.32-1.39) 1.25 (1.18-1.31) 
Smokers % 2.0 1.7 22.7 11.5 1.9 1.3 17.2 19.2 
*geometric mean; Data are age and cohort adjusted mean (95 % CI) and percentage. 
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5.1.2 Comparison of BMI with central obesity measures in relation to type 2 diabetes (I, 
III)  
The ORs (I) and HRs (III) for BMI, WC, WHR and WSR with diabetes were estimated and 
compared, using paired homogeneity tests, based on the pooled data. The results of the 
homogeneity tests (BMI with each of the three central obesity measures) showed that the OR 
for BMI did not differ from that for WC or WHR, but was lower than that for WSR (p = 
0.001) with undiagnosed diabetes in men (Figure 7a). In women the ORs were higher for WC 
and WSR than for BMI (both p < 0.05) (Figure 7b). The same results were observed for 
individuals < 50 years of age but the ORs for these indicators did not differ for individuals ≥ 
50 years of age (Figures 7a and 7b). The AUCs were slightly larger for diabetes for WSR of 
0.735 (0.748) in men (women) and WC 0.749 (women only) than for BMI of 0.725 (0.742) in 
Figure 8a, but their 95% CIs were all overlapped, indicating no differences were observed 
between these measures.  
 
The paired homogeneity tests were also performed, based on data in which the studies of the 
same ethnic groups were pooled together (Table 7). With prevalent diabetes, the ORs for the 
BMI and central obesity indicators differed neither in men nor women for any ethnic group, 
except for the men of Filipino and Mauritian Indian ethnicity in which the ORs for WSR were 
higher than for BMI. For Filipino women, the ORs for the central obesity indicators were 
higher than for BMI for prevalent diabetes.  
 
For diabetes incidence in the Mauritius survey, multivariable (baseline fasting glucose, 
cohort, triglyceride, family history of diabetes, blood pressure, and SES) adjusted HRs 
corresponding to a 1 SD increase in baseline BMI, WC, WHR and WSR for Mauritian 
Indians were 1.49 (1.31 - 1.71), 1.58 (1.38 - 1.81), 1.54 (1.37 - 1.72) and 1.61 (1.41 - 1.84) in 
men and 1.33 (1.17 - 1.51), 1.35 (1.19 - 1.53), 1.39 (1.24 - 1.55) and 1.38 (1.21 - 1.57) in 
women, respectively. For Mauritian Creoles they were 1.86 (1.51 - 2.30), 2.07 (1.68 - 2.56), 
1.92 (1.62 - 2.26) and 2.17 (1.76 - 2.69) in men and 1.29 (1.06 - 1.55), 1.27 (1.04 - 1.55), 1.24 
(1.04 - 1.48) and 1.27 (1.04 - 1.55) in women (III). The paired homogeneity tests showed that 
there was no difference between BMI and each of the central obesity indicators with diabetes 
incidence, as shown in Table 7 (all p > 0.05). 
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Figure 7a Odds ratio (black diamond) and 95% CI (solid line) for diabetes corresponding to 1 SD increase in BMI, WC, WHR,  
and WSR in men 
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Figure 7b Odds ratio (black diamond) and 95% CI (solid line) for diabetes corresponding to 1 SD increase in BMI, WC, WHR, and WSR in 
women
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 2.41 (1.30, 4.46) 
 1.53 (0.58, 4.06) 
 2.05 (1.50, 2.80) 
 1.44 (1.07, 1.92) 
 1.63 (1.10, 2.43) 
 1.52 (1.19, 1.94) 
 1.77 (1.43, 2.19) 
 1.98 (1.47, 2.66) 
 2.47 (1.56, 3.91) 
 1.32 (0.87, 2.01) 
 1.91 (1.62, 2.25) 
 1.57 (1.39, 1.76) 
 2.07 (1.58, 2.70) 
 1.71 (1.52, 1.92) 
 1.60 (1.47, 1.75) 
 1.87 (1.67, 2.10) 
 1.70 (1.59, 1.83) 
WHR 
0.5 1 2 5 10 
China, Beijing 1.16 (0.96, 1.40) 
China, Hong Kong 1.72 (1.39, 2.13) 
China, Hong Kong workforce 1.99 (1.24, 3.20) 
China, Qing Dao 1.34 (1.09, 1.65) 
China, Shunyi 1.09 (0.88, 1.35) 
Japan, Funagata 2.25 (1.26, 4.01) 
Brazil, São Paulo92-93 2.46 (0.77, 7.82) 
Brazil, São Paulo99-00 1.73 (1.27, 2.35) 
India, Chennai94 1.61 (1.19, 2.17) 
India, CUPS 1.18 (0.82, 1.70) 
India, CURES 1.30 (1.04, 1.62) 
Mauritius, Mauritius87 1.80 (1.44, 2.24) 
Mauritius, Mauritius92 1.52 (1.14, 2.03) 
Mauritius, Mauritius98 1.46 (1.01, 2.11) 
Mongolian National Survey 1.33 (0.88, 2.02) 
Philippines Diabetes Survey 2.14 (1.78, 2.58) 
All Chinese 1.32 (1.19, 1.46) 
All Japanese 1.86 (1.43, 2.42) 
All Indian 1.49 (1.33, 1.67) 
Aged>=50 years 1.45 (1.32, 1.58) 
Aged < 50 years 1.67 (1.50, 1.87) 
All women 1.50 (1.40, 1.60) 
WC 
0.5 1 2 5 10 
 1.36 (1.08, 1.70) 
 2.49 (1.91, 3.25) 
 2.00 (1.27, 3.15) 
 1.34 (1.08, 1.67) 
 1.34 (1.04, 1.72) 
 2.23 (1.24, 4.00) 
 2.28 (0.82, 6.33) 
 2.07 (1.51, 2.82) 
 1.45 (1.08, 1.93) 
 1.66 (1.11, 2.47) 
 1.49 (1.17, 1.90) 
 1.83 (1.48, 2.27) 
 1.85 (1.39, 2.46) 
 2.38 (1.51, 3.75) 
 1.31 (0.87, 1.98) 
 1.95 (1.65, 2.30) 
 1.55 (1.38, 1.74) 
 2.11 (1.62, 2.76) 
 1.70 (1.51, 1.91) 
 1.63 (1.49, 1.78) 
 1.82 (1.63, 2.04) 
 1.70 (1.58, 1.82) 
BMI 
0.5 1 2 5 10 
China, Beijing 1.35 (1.07, 1.70) 
China, Hong Kong 2.07 (1.64, 2.60) 
China, Hong Kong workforce 1.86 (1.20, 2.88) 
China, Qing Dao 1.19 (0.97, 1.46) 
China, Shunyi 1.53 (1.18, 1.99) 
Japan, Funagata 2.13 (1.29, 3.51) 
Brazil, São Paulo92-93 2.21 (0.86, 5.65) 
Brazil, São Paulo99-00 2.10 (1.54, 2.84) 
India, Chennai94 1.21 (0.91, 1.60) 
India, CUPS 1.52 (1.05, 2.21) 
India, CURES 1.46 (1.14, 1.86) 
Mauritius, Mauritius87 1.72 (1.39, 2.13) 
Mauritius, Mauritius92 1.81 (1.40, 2.34) 
Mauritius, Mauritius98 2.24 (1.49, 3.37) 
Mongolian National Survey 1.38 (0.94, 2.04) 
Philippines Diabetes Survey 1.60 (1.37, 1.86) 
All Chinese 1.50 (1.34, 1.67) 
All Japanese 2.11 (1.64, 2.71) 
All Indian 1.60 (1.43, 1.79) 
Aged>=50 years 1.55 (1.42, 1.69) 
Aged < 50 years 1.62 (1.46, 1.80) 
All women 1.59 (1.48, 1.70) 
55 
 
a 
 
b  
 
 
 
Figure 8 Areas under the curves from ROC curve analysis for BMI, WC, WHR, and WSR in 
relation to diabetes (a) and hypertension (b) 
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Table 7 Paired homogeneity test results (p values) between BMI and central obesity indicators 
in its association with diabetes and hypertension  
 
Ethnicity Number 
of 
subjects 
Diabetes prevalence Hypertension prevalence 
Men 9095 WC WHR WSR WC WHR WSR 
Chinese 2980 0.246 0.604 0.081 0.120 < 0.001** 0.048** 
Filipino 1351 0.127 0.202 0.013* 0.114 0.002** 0.374 
Japanese 1040 0.620 0.623 0.377 0.182 0.046** 0.739 
Native Indian 1232 0.783 0.625 0.684 0.976 0.038** 0.926 
Mauritian 
Indian 
1576 0.520 0.615 0.035* 0.074 0.912 0.447 
Mongolian 916 0.714 0.568 0.868 0.360 0.002** 0.561 
Women 11732   
Chinese 3850 0.493 0.123 0.496 0.480 < 0.000** 0.166 
Filipino 2490 0.010* 0.011* 0.005* 0.042** 0.009** 0.002** 
Japanese 1257 0.701 0.330 0.395 0.141 0.124 0.780 
Native Indian 1353 0.123 0.999 0.102 0.733 0.002** 0.873 
Mauritian 
Indian 
1707 0.513 0.274 0.525 0.620 0.240 0.903 
Mongolian 1075 0.560 0.801 0.603 0.766 0.016** 0.900 
  Diabetes incidence Hypertension incidence 
Men 1841       
Mauritian 
Indian 
1345 0.207 0.922 0.122 0.796 0.476 0.903 
Mauritian 
Creole 
496 0.283 0.831 0.120 0.073 0.100 0.002* 
Women 2104       
Mauritian 
Indian 
1525 0.809 0.519 0.334 0.249 0.047** 0.508 
Mauritian 
Creole 
579 0.697 0.625 0.536 0.120 0.068 0.981 
*BMI is weaker and **BMI is stronger 
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5.1.3 Comparison of BMI with central obesity measures in relation to hypertension (I, 
II)  
The ORs (I) and HRs (II) for BMI, WC, WHR and WSR with hypertension were estimated 
and compared, using paired homogeneity tests based on the pooled data. As shown by these 
homogeneity tests, the ORs for BMI did not differ from those for WC and WSR with 
hypertension, but the ORs for BMI were significantly higher than those for WHR (p < 0.001) 
in men (Figure 9a) and were highest for BMI than for WHR (p < 0.001), WSR (p < 0.01) and 
WC (p < 0.05) in women (Figure 9b). The AUCs for hypertension were slightly larger for 
BMI of 0.760 (0.766) than for WHR of 0.748 (0.751) in Figure 8b, but their 95% CIs were all 
overlapped, indicating that there were no differences between these measures.  
 
When the analysis was performed by ethnic groups (Table 7), the ORs for BMI did not differ 
from those for WC and WSR, but were higher for BMI than for WHR in both men and 
women, regardless of age (Figures 9a and 9b) for most of the ethnic groups, with a few 
exceptions.  The ORs did not differ between BMI and central obesity indicators in Mauritian 
Indians (men and women) and Japanese women. For Filipino women, the OR was highest for 
BMI than for the other three central obesity measures with hypertension.  
 
For hypertension incidence, HRs adjusting for baseline systolic blood pressure, smoking, total 
cholesterol and cohort, corresponding to a 1 SD increase in BMI, WC, WHR and WSR were 
1.20 (1.24), 1.19 (1.21), 1.14 (1.10) and 1.20 (1.26) in Mauritian Indian men (women) and 
1.23 (1.32), 1.34 (1.23), 1.41 (1.13) and 1.43 (1.33) in Mauritian Creoles, indicating that all 
obesity indicators significantly predicted hypertension incidence, except for WHR in 
Mauritian Creole women. The paired homogeneity tests showed that the ORs for BMI did not 
differ from those for the other three measures for most of the comparisons, with two 
exceptions: the OR for WSR was stronger than that for BMI (p = 0.002) in Mauritian Creole 
men, but the OR for BMI was stronger than that for WHR (p = 0.047) in Mauritian Indian 
women in predicting incident cases of hypertension (Table 7).  
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Figure 9a Odds ratio (black diamond) and 95% CI (solid line) for hypertension corresponding to 1 SD increase in BMI,  
WC, WHR, and WSR in men 
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Mauritius, Mauritius87 1.40 (1.20, 1.64) 
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Figure 9b Odds ratio (black diamond) and 95% CI (solid line) for hypertension corresponding to 1 SD increase in BMI,  
WC, WHR, and WSR in women 
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India, Chennai94 1.99 (1.53, 2.58) 
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All Japanese 1.30 (1.12, 1.51) 
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5.2 Prevalence of the metabolic syndrome in populations of Asian origin---
Comparison of the IDF definition with the NCEP definition (IV) 
5.2.1 Characteristics of the DECODA study cohorts 
In this analysis, individuals from nine cohorts in the DECODA study were included. The 
mean WC of Japanese was similar to that for Chinese and Indians (Mauritian and Asian 
Indians), while Japanese women had a lower mean WC than Japanese men, as in other ethnic 
groups. In general, men had higher mean blood pressure, larger mean WC, mean triglyceride 
and lower mean HDL cholesterol than women, but women had higher mean 2-h PG than men.  
5.2.2 Prevalence of central obesity using the 2005 IDF definition and its comparison with 
the NCEP definition 
The age-standardized prevalence of central obesity is shown in Figure 10. Application of the 
2005 IDF criteria resulted in a higher prevalence of central obesity than when the NCEP 
criteria were used, except in Japanese women who had an extremely low prevalence of central 
obesity using the 2005 IDF definition. When the same criteria were applied to Japanese as to 
Chinese and Asian Indians, the prevalence of central obesity in Japanese was comparable to 
that of other ethnic groups in both men and women (Figure 10). The prevalence ratio of IDF 
to NCEP was 1.5 (1.5), 2.7 (0.4), 1.2 (1.2) and 1.0 (1.3) in Chinese, Japanese, Mauritian 
Indian and native Asian Indian men (women) respectively. The ratios were similar in all, 
except for Japanese, in which the ratio was high for Japanese men and low for Japanese 
women. When the same obesity criteria for Japanese as for others were used, the ratio for 
Japanese was 1.5 in both genders. 
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Figure 10 The age-standardized prevalence of central obesity (%) defined by the NCEP 
criteria (black) and the IDF criteria (blank). Using the same waist circumference for  
Japanese as for Chinese and Indians (lined). M/Indians represent Indians from Mauritius. 
N/Indians represent Indians from India. 
 
 
 
 
 
 
 
 
 
62 
 
5.3 Ethnic differences of the association of undiagnosed type 2 diabetes with 
obesity (V) 
5.3.1 Characteristics of the DECODA and DECODE study population 
Europeans had a higher mean BMI of 27 kg/m
2
 and WC of 94 cm (men only) than other 
ethnic groups (Tables 5 and 8). The mean BMI did not differ between men and women for a 
given ethnic group. The mean WC was higher by about 5 cm for Chinese, Japanese and 
Indian men than for women, but about 10 cm higher in European men than in European 
women. The crude prevalence (total) of undiagnosed diabetes ranged from 9.5% to 13.2% 
among Asian Indians living in India and Mauritius, from 4.7% to 10.2% in Japanese and 
Chinese and from 4.7% to 6.4% in Europeans.  
5.3.2 Ethnic difference in the strength of association of undiagnosed type 2 diabetes with 
BMI and WC 
The prevalence of undiagnosed diabetes was highest in Asian Indians, lowest in Europeans 
and intermediate in others, given the same BMI (Figure 11) or WC (Figure 12) category 
across the BMI or WC ranges. The ethnic differences in prevalence of diabetes at each 
category of the BMI or WC were statistically significant (p < 0.05 for all BMI or WC 
categories). The  coefficients corresponding to a 1 SD increase in BMI were 0.34/0.28, 
0.41/0.43, 0.42/0.61, 0.36/0.59 and 0.33/0.49 for Asian Indian, Chinese, Japanese, Mauritian 
Indian and European men/women (overall homogeneity test: p > 0.05 in men and p < 0.001 in 
women in Figure 13a) and in WC 0.31/0.31, 0.30/0.46, 0.22/0.57 and 0.38/0.58 for Asian 
Indians, Chinese, Mauritian Indians and Europeans, respectively (overall homogeneity test: p 
> 0.05 in men and p < 0.001 in women in Figure 13b). Asian Indian women had lower  
coefficients than women of other ethnic groups. 
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Table 8 Characteristics of the DECODE study cohorts 
 Men     Women     
 Mean  
age (range)   
Number 
of 
subject 
BMI 
(kg/m
2
) 
Waist  (cm) 
 
DM 
(%) 
Mean 
age (range)   
Number  
of 
subject 
BMI  
(kg/m
2
) 
Waist  (cm) 
 
DM  
(%) 
European 55 (30-83) 9792 27.0 (0.04) 95.4 (0.10) 6.4 55 (30-88) 11 187 26.9 (0.04) 84.5 (0.11) 4.7 
Cremona, Italy 57 (40-83)  729 26.7 (0.14) 93.8 (0.38) 3.3 59 (40-88) 933 25.6 (0.14) 84.3 (0.36) 3.4 
Viva, Spain 49 (34-69) 880 27.5 (0.12) 94.2 (0.34) 4.3 49 (34-66) 1058 28.1 (0.13) 85.7 (0.33) 3.2 
Nicosia, Cyprus 51 (30-80) 463 27.8 (0.17) 98.4 (0.47) 8.4 52 (30-83) 483 26.9 (0.20) 86.9 (0.49) 3.1 
Ely Study, UK 54 (40-67)  483 26.2 (0.17) 91.36  (0.46) 8.5 54 (40-69) 625 25.8 (0.17) 77.6 (0.43) 6.1 
National FINRISK Study 
1987, Finland  
54 (44-64) 1261 27.6 (0.10) 95.2 (0.29) 3.1 54 (44-64) 1427 27.7 (0.11) 82.2 (0.29) 3.7 
National FINRISK Study 
1992, Finland 
54 (44-64) 843 27.7 (0.13) 97.7  (0.35) 6.3 54 (44-64) 1016 27.0 (0.14) 82.5 (0.34) 4.1 
National FINRISK Study 
2002, Finland 
59 (45-74)  1645 27.9 (0.09) 97.5  (0.25) 11.7 57 (45-74) 1938 27.5 (0.10) 85.2 (0.25) 6.3 
Savitaipale, Finland 53 (42-69)  549 26.2 (0.16) 93.9 (0.43) 7.5 54 (42-67) 553 26.3 (0.18) 84.2 (0.46) 5.6 
Hoorn Study, The Netherlands 61 (49-77) 1097 26.3 (0.11) 94.6 (0.31) 7.4 62 (49-77) 1274 26.4 (0.12) 84.3 (0.31) 6.5 
Newcastle Heart Project , UK 55 (30-75) 393 26.3 (0.18) 92.6 (0.51) 8.9 55 (30-76) 373 26.3 (0.22) 79.5 (0.56) 6.2 
Swedish MONICA1986 47 (30-64)  280 25.5 (0.22) 93.4 (0.61) 2.5 47 (30-64) 270 25.2 (0.26) 84.6 (0.66) 2.6 
Swedish MONICA1990 47 (30-64) 330 25.8 (0.20) 92.0 (0.56) 1.2 47 (30-64) 366 25.4 (0.23) 80.8 (0.57) 0.8 
Swedish MONICA1994 53 (30-74)  427 26.4 (0.18) 93.7 (0.49) 4.2 52 (30-74) 456 26.0 (0.20) 84.6 (0.51) 4.8 
Swedish MONICA 2004 53 (30-75) 412 27.5 (0.18) 96.9  (0.50) 4.4 53 (30-75) 415 26.6 (0.21) 85.9 (0.53) 4.1 
Data are age adjusted mean (SE). DM denotes diabetes prevalence. 
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Figure 11 Crude (filled markers) prevalence and estimated (open markers with 95% CIs) 
probability of undiagnosed diabetes according to BMI categories by ethnicity 
 
 
 
Figure 12 Crude (filled markers) prevalence and estimated (open markers with 95% CIs) 
probability of undiagnosed diabetes according to the waist categories by ethnicity 
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Figure 13 (a) β coefficients (95 % CI) for undiagnosed diabetes corresponding to a one SD 
increase in BMI (kg/m
2
) and (b) in waist circumference 
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5.4 Assessment of change points for the presence of undiagnosed type 2 
diabetes with BMI and WC in different ethnic groups (VI)  
There were marked variations in the mean change points of BMI or WC (Table 9) for 
detecting undiagnosed diabetes among the ethnic groups. The mean change points were 7 - 8 
units higher for BMI and 14 - 20 cm for WC in Europeans than in Asian Indians and 
Mauritian Indians (not for BMI). Similar BMI of 24 - 25 kg/m
2
 change points were detected 
in men and women of Chinese, Japanese, and Mauritian Indians. The mean WC change point 
was about 15 cm higher in European men than in Chinese men, but there was no difference 
among Asian men while the differences were statistically significant among ethnic groups in 
all paired comparisons among women.    
     
The change points detected, based on the age-adjusted Bayesian model, were not different 
from those based on the unadjusted Bayesian model for age in most situations, except for 
BMI in Japanese men (one unit lower) and for WC in European men (2 cm higher) and 
European women (4 cm higher). The change points based on the unadjusted Bayesian model 
differed from the cutoff values obtained based on the ROC curve approach. The difference in 
mean values of BMI and WC, based on ROC and Bayesian change point method, varied from 
-1 to +2 kg/m
2
 for BMI but from +1 to +7 cm for WC. The ROC approach, in general, 
produced higher cutoff values than the Bayesian analysis. 
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Table 9 BMI and WC change points based on Bayesian model and the optimal cutoff values using ROC curve analysis and their performance for 
screening of undiagnosed diabetes in different ethnic groups 
 
Ethnicities Total 
number (DM) 
BMI cutoff WC cutoff 
  Bayesian model-mean change points (95 % 
credible intervals) 
ROC 
curve analysis 
Bayesian model-mean change points (95 % 
credible Intervals) 
ROC 
curve analysis 
  Age-adjusted Un-adjusted  Age-adjusted Un-adjusted  
Men 25 250 (2282)       
Asian Indian 6176 (779) 21.5 (20.2-21.9) 21.3 (19.7-21.9) 22.5 79 (77-82) 80 (77-82) 85 
Chinese 4162 (426)  25.6 (24.0-26.9) 25.6 (24.2-26.9) 25.8 84 (82-85) 84 (82-85) 87 
Japanese 2997 (181) 24.0 (21.7-29.7) 25.5 (21.6-30.9) 24.1 NA NA NA 
Mauritian 
Indian 
2123 (265) 24.0 (23.0-25.9) 24.6 (23.0-25.9) 24.5 78 (77-80) 78 (77-83) 84 
European 9792 (631) 29.5 (29.0-29.9) 29.5 (29.0-29.9) 27.0 99 (95-106) 97 (95-100) 98 
Women 30 788 (2409)       
Asian Indian 7361 (881) 22.5 (22.0-23.0) 22.3 (18.3-23.7) 23.1 75 (74-76) 75 (74-76)  82 
Chinese 5813 (587) 25.2 (23.6-26.9) 24.6 (24.0-26.3) 25.4 81 (79-82) 81 (79-82) 82 
Japanese 4045 (192) 25.3 (23.0-29.7) 25.4 (23.1-29.5) 25.3 NA NA NA 
Mauritian 
Indian 
2382 (227) 24.9 (23.6-25.9) 24.7 (23.9-25.9) 25.7 81 (80-82) 81 (80-82) 84 
European 11187 (522) 29.4 (28.3-29.9) 28.6 (27.0-29.9) 28.2 89 (86-91) 85 (83-91) 86 
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6 DISCUSSION 
6.1 Study design and methodology 
The strengths of the DECODA and DECODE studies are that individual participant data from 
each population rather than aggregate data were used. Most of the studies were population-
based or community-based with random sampling, except for the Hong Kong Workforce 
(occupational study) and Hisayama (community-based study). This collaborative analysis 
furthered our opportunities to explore ethnic, age and sex differences in diabetes and 
hypertension with obesity, based on large sample size for a given ethnic group with more 
statistical power than individual studies. Most importantly, undiagnosed or newly diagnosed 
diabetes prevalence or incidence was defined by both FPG and standard 2-h PG following 75- 
g OGTTs in all studies (not for all individuals in the FINRISK studies) (III, V, VI). We 
previously reported that FG criteria alone underestimated the prevalence of diabetes by up to 
30% (Qiao et al. 2000). Anthropometric measures were taken by trained observers in all 
studies, rather than as self-reports. The sample size sufficient for a given ethnic group in the 
DECODA/DECODE studies allowed exclusion of individuals with prior history of diabetes 
and hypertension, because treatment and duration of these diseases could affect weight and 
WC, as well as glucose and blood pressure levels. Moreover, the early detection should target 
undiagnosed diabetes or hypertension.  
 
Two of the six articles in the present study were based on the Mauritius surveys, a series of 
population-based prospective studies with random sampling, covering 13 areas and using 
similar study protocols in all surveys. The repeated measures of anthropometrics, blood 
pressure, glucose, lipids, uric acid and other variables furthered our opportunity to study the 
incidence in diabetes, hypertension, obesity and many other risk factors for Mauritian Indians 
and Creoles. For statistical analysis, several important approaches were applied in the data 
analysis, such as paired homogeneity test and the Bayesian change point analysis (for the first 
time), which has not been used widely in this research area.  
 
A limitation of the study was that although the laboratory assays for glucose and lipids, as 
well as anthropometric measurements, were similar among most of the studies, there was no 
standardization in measurement methods among the different laboratories and studies. In two 
studies, WC was measured, using different measurement protocols. Thus, taking into account 
these differences, study-, sex-, or ethnic-specific SD was used to standardize continuous 
variables in the collaborative data analysis.  
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A further limitation was that the various studies were performed over a long time period from 
1986 to 2006. The prevalence of diabetes increased with time and the higher prevalence in 
Asians than in Europeans may have been due to the fact that most of the Asian studies were 
carried out in the late 1990s and in early 2000. However, in comparing the contemporary 
studies, we found that the prevalence of undiagnosed or newly diagnosed diabetes was still 
lower in Europeans than in Asians, indicating that the study period did not affect the 
prevalence substantially. Most of the Chinese studies were from North China and future 
studies need to examine change point values in individuals from South China, considering the 
body size differences between North and South Chinese. The small sample size for Filipinos 
and Mongolians did not allow us to estimate the change point values for BMI or WC for these 
ethnic groups and more studies are needed.  
6.2 Comparison of BMI with central obesity measures in relation to 
undiagnosed diabetes and hypertension 
Our findings showed that all four anthropometric measures of obesity were significantly 
associated with either diabetes or hypertension (I) or predicted hypertension (II) and diabetes 
(III) incidence, indicating the importance of obesity in the prevention of type 2 diabetes and 
hypertension. In the cross-sectional study (I), the predictive ability between BMI and WC or 
WHR did not differ, but WSR (WC in women only) was a better predictor than BMI in 
assessing diabetes risk in Asians. Investigators from the OAC study compared the BMI with 
WC and WHR, using the homogeneity test as we used with prevalent diabetes for Asians, in 
which the major ethnic groups from Asia were also pooled (Huxley et al. 2008). Limiting to 
these three measures, our finding for Asian men was different from that reported for Asian 
men in the OAC in which WHR was significantly better than BMI for prevalent diabetes. For 
Asian women, WC was significantly better than BMI in both OAC and our studies, but with 
the difference that WHR was also better than BMI in the OAC study, but not in our study. 
However, these two studies differ in that diabetes was defined by both fasting and 2-h glucose 
(not for Mongolians and Filipinos) in our study, but fasting glucose alone was used in the 
OAC. A meta-analysis was conducted to compare pooled AUCs for BMI with that for WC, 
WHR and WSR with diabetes (Lee et al. 2008a). They found that the AUC for WSR was 
significantly larger than that for BMI in Asian men, with no difference in Asian women. In 
our study, the AUCs for these anthropometric measures did not differ in either men or 
women. Furthermore, the predictive ability of the four anthropometric measures with incident 
diabetes did not differ in either Mauritian Indians or Mauritian Creoles after multivariable 
adjustment (III). These findings were consistent with results of the DPP from the USA 
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(Diabetes Prevention Program Research Group 2006) and meta-analysis (Vazquez et al. 
2007). However, our findings were different from that reported for Pima Indians, in which 
BMI predicted the diabetes incidence better than WC or WHR (Tulloch-Reid et al. 2003) or 
WC or WSR predicted better than BMI for Mexican Americans (Wei et al. 1997), African 
Americans (Stevens et al. 2001a) and Iranian women (Hadaegh et al. 2009). A recent study in 
British men and women, 60-79 years of age, an over 7-year follow-up, showed that WC was a 
stronger predictor of diabetes incidence than BMI and WHR in elderly women, while BMI 
and WC were equal predictors in elderly men (Wannamethee et al. 2010).  
 
For assessing hypertension risk (I), there was no difference between BMI and WC or WSR in 
Asian men, while in Asian women BMI was a better measure than the central obesity 
measures based on pooled data in our study. Our finding that BMI was associated 
significantly better than WHR with prevalent hypertension in both men and women (also by 
ethnic group) was similar to that reported for Asian men and women in the OAC study 
(Huxley et al. 2008). In the meta-analysis no difference was seen among the four measures in 
women and WSR was better than BMI in men with prevalent hypertension (Lee et al. 2008a). 
Moreover, the predictive ability between BMI and the other three obesity indicators for 
hypertension incidence did not differ in Mauritian Indians and Mauritian Creoles during 
follow-ups of 5,6 and 11 years (II). Few population-based prospective studies have compared 
these anthropometric indicators with incident hypertension and the findings were inconsistent: 
in favour of the WC in Brazilians (Fuchs et al. 2005) and African Caribbeans (Nemesure et al. 
2008), but in favour of the BMI for Caucasian women from the USA (Shuger et al. 2008) and 
Greek adults (Panagiotakos et al. 2009) and no difference was found in other studies (Folsom 
et al. 2000; Woo et al. 2002; Chuang et al. 2006). The reasons for these inconsistent findings 
are not clear and further research is needed, using an appropriate statistical analysis based on 
large prospective studies in different populations at the community level with a further 
emphasis on age effect.   
6.3 Role of central obesity in the metabolic syndrome 
Asian women, particularly elderly women, had a higher prevalence of the metabolic 
syndrome than Asian men (IV). This, however, did not apply to Japanese, using the 2005 IDF 
definition, in which obesity for Japanese was defined differently from their Asian 
counterparts. The 2005 IDF definition did not detect leaner subjects with hypertension and 
dyslipidemia. It brought a dramatic rise in the prevalence of central obesity that compared 
with the NCEP definition in Chinese and Indians, was 7 – 16 times higher in men and 2 - 3 
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times higher in women. However, this resulted in 52 times higher prevalence in Japanese 
men, but in Japanese women the IDF criteria gave a dramatically lower prevalence. This 
indicates that the cutoff values for central obesity have been set inappropriately for Japanese. 
Our study, among few others strongly indicated that the 2005 IDF criteria for central obesity 
for Japanese needed reconsideration. The 2005 IDF criteria for central obesity for Japanese 
were corrected in 2006 (Alberti et al. 2006) and central obesity is not mandatory component 
in the 2009 IDF definition of the metabolic syndrome (Alberti et al. 2009).  
6.4 Ethnic differences in the association of diabetes with obesity 
The results showed that the prevalence of undiagnosed diabetes increased with increasing 
BMI or WC to a similar degree in men but to a lesser degree in Asian Indian women than in 
women of other ethnic groups (V). At the same BMI or WC level the prevalence of diabetes 
was, however, highest in Asian Indians, and lowest in Europeans and intermediate in Chinese, 
Japanese and Mauritian Indians.  
 
The higher prevalence of diabetes at the same BMI or WC level in Asians (or South Asians) 
than in Europeans in our study is in agreement with previous reports (McBean et al. 2004; 
Yoon et al. 2006; Huxley et al. 2008; Stevens et al. 2008; Stommel and Schoenborn 2010). 
The reasons for these ethnic differences remain unknown and may likely be attributed to both 
genetic and nongenetic factors (Yoon et al. 2006; Wulan et al. 2010). The increase in type 2 
diabetes in Asia differed from that reported in other parts of the world i.e. it has increased in a 
shorter time and the onset occurs in younger age groups, and in people with a much lower 
BMI (Yoon et al. 2006; Ramachandran et al. 2010).    
The finding that the weaker association of undiagnosed diabetes with BMI or WC in Asian 
Indian women compared with women of other ethnic groups despite their higher prevalence, 
suggests that there may be other more important biological factors rather than obesity that 
predispose them to higher risk for diabetes. However, these findings differed from those in 
previous reports, since the strength of the association of diabetes with BMI or WC was 
stronger in Chinese than in American Whites (Stevens et al. 2008) or in Asians than in 
Australasians (women only) in the OAC study (Huxley et al. 2008). 
Plasminogen activator inhibitor 1 is inversely associated with the glucose disposal rate in 
Asian Indians but not in Caucasians (Raji et al. 2001). BMI- and age-matched apparently 
healthy Asian Indians were more insulin- resistant, had higher insulin levels, poorer lipid 
profiles, and significantly greater total abdominal and visceral fat than Caucasians. All these 
can increase the risk of diabetes and contribute to the higher prevalence of diabetes. Surrogate 
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obesity measures, such as BMI or WC may not be sensitive measures for visceral adiposity in 
this ethnic group. For migrant Asian Indians in the USA, it was demonstrated that excessive 
insulin resistance is the likely mechanism for the excess prevalence of diabetes in Asian 
Indians. This was independent of obesity and fat distribution (Abate and Chandalia 2007), 
which were due to higher truncal subcutaneous adipose tissue and large dysfunctional 
adipocytes (high NEFA and low adiponectin levels) rather than excess visceral fat in 
nondiabetic South Asian men compared with Caucasian men (Chandalia et al. 2007). It was 
also reported that the ectonucleotide pyrophosphatase/phosphodiesterase 1 121Q gene 
explained almost entirely the ethnic difference in insulin resistance between Caucasians and 
Asian Indians living in Dallas, Texas (Abate et al. 2003) or India (Abate et al. 2005). A recent 
report suggests that the Pro12Ala polymorphism of the pyroxisome proliferator-activated 
receptor gamma gene, which protects against type 2 diabetes and insulin resistance in 
Europeans, was not protective in Asian Indians. Thus, genetic differences could, at least in 
part, be the ‘Asian Indian Phenotype’ of increased susceptibility to type 2 diabetes (Radha et 
al. 2006). In a recent review, the higher risk of metabolic diseases at lower degree of obesity 
in Asians compared with Europeans, was partly due to unfavourable body composition 
(higher body fat percentage, lower lean skeletal muscle and lower gynoid fat) that was more 
pronounced in Asian Indians, followed by Southeast Asians (Malays), and East Asians as 
Chinese or Japanese. The same phenomenon was already noted in Asian Indian adolescents 
(Wulan et al. 2010). In general, Asians tend to store more fat in the abdominal regions.  
6.5 Assessment of change points for the presence of undiagnosed diabetes for 
BMI and WC in different ethnic groups 
The change points detected for BMI and WC for undiagnosed diabetes, using Bayesian 
analysis, varied among ethnicities, which confirms previous findings. The highest BMI and 
WC change points were found for Europeans, followed by Chinese and Japanese, and the 
lowest values for Asian and Mauritian Indians for undiagnosed diabetes with no substantial 
effect of age.  
 
Our results, using the ROC approach were similar to previous reports for a given ethnic 
group. The optimal cutoff values for BMI ranged from 22 - 23 for Asian Indians (Snehalatha 
et al. 2003; Mohan et al. 2007), 23 - 24 for Chinese (Zhou 2002; Li et al. 2008) and Japanese 
(Ito et al. 2003) and 27 - 28 for Europeans in Germany (Stevens et al. 2001a; Diaz et al. 2007; 
Schneider et al. 2007). The optimal WC cutoff values were 85/73 - 80 for Chinese (Ho et al. 
2003; Li et al. 2008), Japanese (Ito et al. 2003) and Asian Indian (Snehalatha et al. 2003) 
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men/women. For White men, it ranged from 97 - 99 cm (Balkau et al. 2006; Huxley et al. 
2007) to 101 - 103 cm in the USA (Stevens et al. 2001a), Germany (Schneider et al. 2007), 
and the UK (Diaz et al. 2007) and 106 cm in the USA (Diaz et al. 2007), while they were 85, 
91 - 94, and 95 - 96 cm, respectively, in women.  
 
For the first time, Bayesian change point analysis was used to detect a change point that does 
not attempt to maximize sensitivity and specificity, as does the ROC curve analysis. The merit 
of the Bayesian analysis model is that it can be easily adjusted for other covariates and 
statistical power is gained by incorporating various ethnic groups in the same hierarchical 
analysis. Moreover, the Bayesian change point is determined according to the changes in 
prevalence of diabetes. Nevertheless, it is worth noting that in spite of the differences in 
statistical methods, the variations between ethnicities were consistent.  
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7 IMPLICATIONS OF THE STUDY FINDINGS 
 
The present study highlights that obesity, as measured by surrogate anthropometric measures, 
is a risk factor for type 2 diabetes and hypertension in the ethnic groups studied. The 
beneficial effect of weight reduction with other lifestyle factors has been acknowledged in 
different populations. Although, most previous studies have shown that central obesity, as 
measured by WC was a better predictor for diabetes or hypertension than general obesity, our 
study found no difference between BMI and WC in their predictive ability. Thus, both can be 
used as screening tools at the community level in men and women of Asian Indian, Chinese, 
Japanese (only BMI studied), Mauritian Indian, and Mongolian ethnicities. This finding is 
important, because the measurement error is less with BMI than with WC and the measure for 
BMI is easy to standardize, thus the results with BMI are easy to compare between different 
populations throughout the world. But research, based on large prospective studies, is still 
required to confirm the findings.   
 
With regard to the change point values for BMI and WC, our study supports previous findings 
that the use of ethnic- and sex-specific values in different populations (Lear et al. 2007) is 
appropriate, although a distinct approach (Bayesian) rather than ROC curve analysis, was 
used. Further research is needed to clarify which of these two methods is better for different 
populations. It would be worthwhile to investigate the future risk of diabetes or hypertension 
associated with the same WC or BMI level by age-group, using the Bayesian approach in 
other populations. Whether the increased susceptibility to diabetes in Asians at the same BMI 
or WC level, compared with Europeans in our study, is due to increased genetic 
predisposition, changes in diet and lifestyle or the interplay of both remains unclear. 
Therefore, longitudinal studies are needed to clarify the mechanism by which body 
composition, body fat distribution, or other genetic, social, cultural, and behavioural factors 
predispose Asians to metabolic diseases.  
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8 CONCLUSIONS 
 
1. Obesity, as measured by surrogate anthropometric measures for general and central obesity, 
is an important risk factor for diabetes and hypertension in all ethnic groups. This highlights 
the importance of obesity in prevention of diabetes and hypertension.   
 
2. Both BMI and WC can be used as screening tools at the community level since they behave 
similarly in their predictive ability for risk assessment for undiagnosed or newly diagnosed 
diabetes, based on both cross-sectional and prospective analysis.  
 
3. For hypertension, BMI was as strong an indicator as that for central obesity measures or 
was an even better measure than WHR in most of the ethnic groups studied.  
 
4. The prevalence of newly diagnosed diabetes increased with increasing BMI or WC to a 
similar degree in men, but to a lesser degree in Asian Indian women than in others. At the 
same BMI or WC levels, however, the prevalence of diabetes was highest in Asian Indians, 
intermediate in Chinese, Japanese, and Mauritian Indians and lowest in Europeans. 
  
5. Ethnic- and sex-specific cutoff/change points of BMI or WC should be considered in 
setting diagnostic criteria for obesity, based on the association of newly diagnosed diabetes 
with BMI or WC.  
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Appendix 1 The most recent adult prevalence (%) of obesity (BMI ≥ 30 kg/m2) measured by trained observers 
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Appendix 2 Secular trend in prevalence of obesity in different regions 
 
Region Prevalence (%) Methodology Reference 
 Men Women   
The USA     
1999-2000 27.5 33.4 NHANES cross studies (Flegal et al. 2010) 
2001-2002 27.8 33.3   
2003-2004 31.1 33.2   
2005-2006 33.3 35.3   
2007-2008 32.2 35.5   
Mexico     
2000 19.4 29.0 Mexican National Health Survey 
(South) 
(Sanches-Castillo et al. 
2003) 
2006 24.2 34.5 National Health and Nutrition Survey (Malina et al. 2007) 
Brazil     
1975 2.7 7.4 National Study on Family 
Expenditure 
(Monteiro et al. 2007) 
1989 5.1 12.4 National Survey on Health and 
Nutrition 
 
2003 8.8 13.0 National Household Budget Survey  
The UK     
1993 13.6 16.9 Health Survey in England annually  (Zaninotto et al. 2009) 
1994 14.4 17.7   
1995 15.6 18.0   
1996 16.9 19.2   
1997 17.0 20.4   
1998 17.6 21.7   
1999 19.3 21.6   
2000 21.5 21.8   
2001 21.3 24.1   
2002 22.5 23.7   
2003 23.2 24.2   
2004 24.0 24.4   
Spain (Girona)   Population-based cross-sectional 
surveys  
(Schroder et al. 2007) 
1995 15.4 15.4   
2000 21.9 21.4   
Sweden   WHO MONICA and INTERGENE  
cohorts 
(Berg et al. 2005) 
1985 6.4 7.2   
1990 9.1 9.8   
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1995 11.5 9.8   
2002 14.8 11.0   
China    (Wang et al. 2007) 
1992 4.9 U  7.5 U China National Nutrition Survey 
1992 and 2002 
 
 1.6 R 2.5 R   
2002 8.7 U 8.0 U   
 3.9 R 5.2 R   
India     
1993-1996 6.2 7.3 The Five City Study Group (urban)  (Singh et al. 2007) 
1992-1993   National Family Health surveys (Wang et al. 2009) 
1998-1999  2.2   
2005-2006  2.8   
Mauritius     
Mauritian 
Indian 
  Mauritius non-communicable disease 
surveys 
(Hodge et al. 1996) 
1987 3.1 10.1   
1992 4.9 14.2   
Mauritian 
Creoles 
    
1987 3.4 12.4   
1992 7.5 20.2   
Mongolia     
1999 13.8 24.6 National Survey (Suvd et al. 2002) 
2005 7.2 12.5 Mongolian NCD Risk Factor Survey (Bolormaa et al. 2008) 
Thailand     
1991 1.6 5.3 National Health Examination 
Surveys 
(Aekplakorn and Mo-Suwan 
2009)  
1997 3.9 7.6   
2004 4.7 9.1   
U and R represent urban and rural 
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Appendix 3 Methodologies used in each study 
Countries 
and studies 
Blood pressure  Fasting and  
2-hour glucose 
Blood sample Waist circumference Hip  
 
China      
Beijing Study  Sitting position, on the right 
arm, with a standard mercury  
sphygmomanometer 
Glucose oxidase 
method, (Hitachi 7170 
Auto analyzer) 
plasma At the minimum 
circumference between 
the rib cage and iliac crest 
 
Maximum circumference 
over the  
greater trochanters 
Hong Kong 
Cardiovascular Risk 
Factor Prevalence Study  
Sitting position, on the right 
arm, after 5  min rest with 
standard mercury  
sphygmomanometer 
Hexokinase method 
(Hitachi 747 analyser 
with  Boehringer  
Mannheim, Germany) 
plasma Half way between 
the xiphisternym 
and the umbilicus 
 
At the level of greater 
trochanters 
Hong Kong Workforce 
survey on CVD 
Risk Factors  
Sitting position, on the right 
arm, after 5  min rest with 
standard mercury  
sphygmomanometer 
Glucose oxidase 
method (Diagnostic Chemicals 
reagent kit, Canada) 
plasma Minimum circumference 
between the umbilicus and 
xiphoid process 
Maximum circumference 
of the buttocks 
posteriorly 
and symphysis pubis 
anteriorly 
Qingdao Diabetes 
Survey 2002  
On the right arm, sitting 
position? 
Glucose oxidase 
method (AMS Analyser 
Medical System, 
SABA-18, Italy) 
plasma At the minimal abdominal 
girth between the rib cage 
and iliac crest 
Maximum horizontal 
girth between the waist 
and thigh 
Qindao Diabetes 
Survey 2006 
 
NA Glucose oxidase 
method (AMS Analyser 
Medical System, 
SABA-18, Italy) 
plasma At the minimal abdominal 
girth between the rib cage 
and iliac crest 
NA 
Shunyi Study In the sitting position, on the 
right arm, with a standard 
mercury sphygmomanometer 
Glucose oxidase 
method, (Hitachi 7170 
Auto analyzer) 
plasma At the minimum 
circumference between  
the rib cage and iliac crest 
Maximum circumference 
over the  
greater trochanters 
Philippine      
The Second  
Philippines National  
Diabetes Survey 
Mercury type 
sphygmomanometer,  
after 15-20 min rest, average 
of  two measurements were 
taken 
Glucose oxidase 
method, Semi-automated dry 
chemistry analyzer  Reflotron 
IV (Boehringer Mannheim, 
distributed by  
Roche, (Philippines) Inc 
capillary glucose After at least 8  
hours fasting,  
midway 
between the lowest 
rib margin and  
the iliac crest 
After at least 8 hours 
fasting, maximum 
circumference over 
 the buttocks 
Japan      
Funagata Diabetes 
Survey90-92  
NA Glucose oxidase method plasma NA NA 
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Funagata Diabetes 
Survey95-97  
Sitting position, after 5 min 
rest using a mercury 
sphygmomanometer 
Glucose oxidase 
method, (GA1160, Arkray, 
Kyoto) 
plasma At umbilicus level At the level of greater 
trochanters 
Hisayama Study 
 
NA Glucose oxidase method 
using Glucoroder-MK2  
(A & T Inc., Tokyo, Japan) 
plasma NA NA 
Ojika91 and 96  NA Glucokinase; 
GPH/Hitachi7250 
plasma NA NA 
Brazil      
São Paulo92-93 After 5 min sitting 
with standard 
mercury sphygmomanometer  
Glucose oxidase method plasma At umbilicus 
 
Maximum circumference 
of the buttocks 
posteriorly and the 
symphysis pubis 
anteriorly 
São Paulo99-00 After 5 min sitting 
using automatic device 
(Omron model HEM-712C, 
Omron Healthcare, Inc, USA)  
Glucose oxidase method plasma At umbilicus Maximum circumference 
of the buttocks 
posteriorly and the 
symphysis pubis 
anteriorly 
India      
Chennai 94 Sitting position, on the right 
arm, with 
mercury sphygmomanometer 
Glucose oxidase-Peroxidase 
(Hitachi 704 Autoanalyser, 
and Boehringer Mannheim, 
Germany reagents) 
plasma The smallest girth between 
the costal margin and iliac 
crests 
Circumference 
at the level of the 
greater trochanters 
Chennai Urban 
Population  
Study (CUPS) 1997  
Sitting position, on the right 
arm, with 
mercury sphygmomanometer 
GOD-POD method, with kit 
(Boehringer Mannheim, 
Germany ) and Ciba Corning 
Express Plus Autoanalyser 
(Corning, Medfield, MA, 
USA) 
plasma Midpoint between the iliac 
crest and the lower margin 
of the rib 
Widest portion of the hip 
over the greater 
trochanter 
 
NUDS 2000  NA Glucose oxidase  
method, Glucometer - Johnson 
& Johnson,  
capillary The smallest girth between 
the coastal margin 
and iliac crests 
NA 
Chennai Urban 
Rural Epidemiological 
Study (CURES) 2004 
Sitting position, on the right 
arm, with 
mercury sphygmomanometer 
Glucose oxidase-peroxidase 
method (Hitachi 912 
Autoanalyser (Hitachi, 
Mannheim, Germany) 
plasma Smallest horizontal 
girth between the 
costal margins and 
the iliac crests at 
minimal respiration 
Widest portion of the hip 
over the 
greater trochanter 
Chennai Study 2006  NA Glucose oxidase-peroxidase plasma The smallest girth between NA 
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 method (Hitachi 912 
Autoanalyser (Hitachi, 
Mannheim, Germany) 
the coastal margin and 
iliac crests 
Mauritius      
Mauritius 87 Sitting position, after 5 min 
rest with standard 
mercury sphygmomanometer 
Yellow Springs Instruments 
(YSI) glucose analyzer, OH, 
USA 
plasma Minimum horizontal 
circumference between 
the umbilicus and 
the xiphoid process 
Maximum circumference 
of the buttocks 
posteriorly and 
the symphysis 
pubis anteriorly 
Mauritius 92 Sitting position, after 5 min 
rest with standard 
mercury sphygmomanometer 
Yellow Springs Instruments 
(YSI) glucose analyzer, OH, 
USA 
plasma Midpoint between  
the iliac crest and 
the lower rib  margin 
Maximum circumference 
of the buttocks 
posteriorly and 
the symphysis 
pubis anteriorly 
Mauritius 98 Sitting position, after 5 min 
rest with standard 
mercury sphygmomanometer 
Yellow Springs Instruments 
(YSI) glucose analyzer, OH, 
USA 
plasma Midpoint between 
the iliac crest and 
the lower rib  margin 
Maximum circumference 
of the buttocks 
posteriorly and 
the symphysis 
pubis anteriorly 
Mongolia      
National Survey 1999  After 10 min rest, in sitting 
position, on the right 
arm, using a standard mercury 
 sphygmomanometer 
(Braunmanometer, England) 
Glucose dehydrogenase 
method, HemoCue  
blood glucose  
analyzer (HemoCue 
AB, Ängelholm, Sweden) 
the whole  
blood 
Midpoint between 
the iliac crest and 
the lower rib margin  
Maximum circumference 
over the  
greater trochanters 
 
Cyprus,      
Nicosia 
Diabetes Study  
NA Hexokinase/Cobas  
Mira Plus Roche 
the whole 
 blood 
Midway between  
the lower rib margin and  
the iliac crest 
NA 
Finland      
The National FINRISK 
Study 1987  
NA Glucose dehydrogenase the whole 
 blood 
Midway between 
the lower rib  margin and 
iliac crest 
NA 
The National FINRISK 
Study 1992  
NA Glucose dehydrogenase plasma Midway between  
the lower rib margin and  
iliac crest 
NA 
The National FINRISK 
Study 2002  
NA Hexokinase assay  
(Thermo Electron Oy) 
plasma Midway between  
the lower rib margin  
and  iliac crest 
NA 
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Savitaipale study  NA Glucose  
dehydrogenase (Hemocue) 
the whole 
 blood 
Midway between the  
lower rib margin and  
iliac crest 
NA 
Italy      
Cremona Study  NA GOD-PAP glucose 
 oxidase (Boehringer 
Mannheim, Milan, Italy) 
plasma At umbilicus NA 
The Netherlands      
Hoorn Study  NA Glucose dehydrogenase 
 (Merck, 
Darmstadt, Germany) 
plasma Midway between 
the lower rib  margin  
and iliac crest 
NA 
Spain      
Viva study NA Hexokinase method, 
HITACHI 
plasma Midway between 
the lower rib  margin  
and iliac crest 
NA 
Sweden      
Swedish MONICA 
1986 
NA Glucose oxidase 
(Beckman analyzer) 
plasma Midway between  
the lower rib margin and  
iliac crest 
NA 
Swedish MONICA 
1990 
NA Glucose oxidase 
(Beckman analyzer) 
plasma Midway between  
the lower rib margin and  
iliac crest 
NA 
Swedish MONICA 
1994 
NA Glucose oxidase 
(Beckman analyzer) 
plasma Midway between the 
lower rib margin and  
iliac crest 
NA 
Swedish MONICA 
2004 
NA Glucose oxidase 
(Beckman analyzer) 
plasma Midway between  
the lower rib margin and  
iliac crest 
NA 
United Kingdom, 
Ely Study  
NA Hexokinase assay plasma Midway between  
the lower rib  margin and 
iliac crest 
NA 
Newcastle Study NA Glucose oxidase 
(Hitachi 717 analyser) 
plasma Midpoint between 
the lower costal  
margin and the 
superior iliac crest 
NA 
NA means not included in the respective analysis. 
